#  @Psyched_Alpha Psychedelic Alpha
Psychedelic Alpha posts on X about $nlb, $mmed, $numi, $mnmd the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.
### Engagements: [-----] [#](/creator/twitter::1250887511087472647/interactions)

- [--] Week [-----] -90%
- [--] Month [------] +85%
- [--] Months [-------] -80%
- [--] Year [-------] +324%
### Mentions: [--] [#](/creator/twitter::1250887511087472647/posts_active)

- [--] Week [--] -23%
- [--] Month [--] +43%
- [--] Months [---] +87%
- [--] Year [---] +260%
### Followers: [------] [#](/creator/twitter::1250887511087472647/followers)

- [--] Week [------] no change
- [--] Month [------] +0.29%
- [--] Months [------] +2.40%
- [--] Year [------] +5.10%
### CreatorRank: undefined [#](/creator/twitter::1250887511087472647/influencer_rank)

### Social Influence
**Social category influence**
[finance](/list/finance) [stocks](/list/stocks) [countries](/list/countries) [exchanges](/list/exchanges) [travel destinations](/list/travel-destinations) [celebrities](/list/celebrities) [technology brands](/list/technology-brands) [cryptocurrencies](/list/cryptocurrencies) [social networks](/list/social-networks) [currencies](/list/currencies)
**Social topic influence**
[$nlb](/topic/$nlb), [$mmed](/topic/$mmed), [$numi](/topic/$numi), [$mnmd](/topic/$mnmd), [health](/topic/health), [$cmps](/topic/$cmps), [$enbi](/topic/$enbi), [$cybn](/topic/$cybn), [$atai](/topic/$atai), [alpha](/topic/alpha)
**Top accounts mentioned or mentioned by**
[@uchidakeiopsy](/creator/undefined) [@joshhardman](/creator/undefined) [@calyxlaw](/creator/undefined) [@healingadvfunds](/creator/undefined) [@greenstarbio](/creator/undefined) [@eleusianbio](/creator/undefined) [@psychedelicunit](/creator/undefined) [@alelagunes](/creator/undefined) [@rickdoblin](/creator/undefined) [@maps](/creator/undefined) [@aicherhelena](/creator/undefined) [@theborislab](/creator/undefined) [@trpwolff](/creator/undefined) [@thebandlab](/creator/undefined) [@doctorchrisvt](/creator/undefined) [@xandvt](/creator/undefined) [@flobrand](/creator/undefined) [@rosmcalpine](/creator/undefined) [@eddietalksdrugs](/creator/undefined) [@henrikjung](/creator/undefined)
**Top assets mentioned**
[COMPASS Pathways plc (CMPS)](/topic/$cmps) [Atai Life Sciences B.V. (ATAI)](/topic/$atai) [Alpha Technology Group Limited (ATGL)](/topic/alpha) [AbbVie Inc (ABBV)](/topic/$abbv) [GH Research PLC (GHRS)](/topic/$ghrs) [TripAdvisor, Inc. (TRIP)](/topic/$trip) [BuzzCoin (BUZZ)](/topic/$buzz) [DMarket (DMT)](/topic/$dmt)
### Top Social Posts
Top posts by engagements in the last [--] hours
"Will $LKYSD be the US OTC ticker for $NUMI Just over an hour ago hints appeared on the OTC Markets register. More here. https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd"
[X Link](https://x.com/Psyched_Alpha/status/1263036103260585985) 2020-05-20T09:17Z 20.3K followers, [--] engagements
"$NUMI US OTC ticker $LKYSD appears to be available for pre-market orders on E-Trade"
[X Link](https://x.com/Psyched_Alpha/status/1263044297642971136) 2020-05-20T09:50Z 20.3K followers, [--] engagements
"Numinus listing day: $NUMI appearing on brokerages some accepting pre-market orders: Will $LKYSD be the US OTC ticker More here: https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numi-begins-appearing-on-brokerages-available-for-pre-market-orders-on-some https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numi-begins-appearing-on-brokerages-available-for-pre-market-orders-on-some"
[X Link](https://x.com/Psyched_Alpha/status/1263068279477862401) 2020-05-20T11:25Z 20.3K followers, [--] engagements
"Did the ticker $LKYSF disappear on your brokerage's app or site It has most likely changed to $LKYSD $NUMI"
[X Link](https://x.com/Psyched_Alpha/status/1263081769022246912) 2020-05-20T12:18Z 20.3K followers, [--] engagements
"We have updated our guide on where you can buy psychedelic stocks in the US and internationally. $NUMI $MMED $SHRM $RVV $HOLL"
[X Link](https://x.com/Psyched_Alpha/status/1263561311633408004) 2020-05-21T20:04Z 20.4K followers, [--] engagements
"Looking to get an overview of the psychedelic stock market Our watchlist displays prices volumes market caps and 5-day changes for the top stocks. Including: $SHRM $MMED $NUMI $HOLL $RVV $BOSS $NLB https://psilocybinalpha.com/psychedelic-stock-watchlist https://psilocybinalpha.com/psychedelic-stock-watchlist"
[X Link](https://x.com/Psyched_Alpha/status/1263601843051155457) 2020-05-21T22:45Z 20.4K followers, [--] engagements
"FYI: TD Ameritrade appears to be experiencing issues. $LKYSD $MMEDF $SHRMF $RVVTF $HSTRF etc"
[X Link](https://x.com/Psyched_Alpha/status/1263828615306924032) 2020-05-22T13:46Z 20.3K followers, [--] engagements
"NewLeaf Brands'announves that their private placement at $0.30 a share with a hold period of [--] months has oversubscribed demand. $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-brands-announces-oversubscription-of-brokered-private-placement-led-by-canaccord-genuity https://psilocybinalpha.com/news/newleaf-brands-announces-oversubscription-of-brokered-private-placement-led-by-canaccord-genuity"
[X Link](https://x.com/Psyched_Alpha/status/1263934338124611584) 2020-05-22T20:46Z 20.3K followers, [--] engagements
"We spoke to Dr. Evan Wood Chief Medical Officer of Numinus $NUMI $LKYSD https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus"
[X Link](https://x.com/Psyched_Alpha/status/1263984236362469376) 2020-05-23T00:05Z 20.3K followers, [--] engagements
"When we spoke to Dr. Evan Wood CMO of Numinus he told us that he expects his incoming team to share the values of putting the public interest first. This is similar to what we have seen in interviews with Numinus' Founder Payton Nyquvest. $NUMI $LKYSD https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus"
[X Link](https://x.com/Psyched_Alpha/status/1264150353970331649) 2020-05-23T11:05Z 20.3K followers, [--] engagements
"Our Psychedelic Stock Watchlist provides a quick-glance overview at the state of the market. Stocks include: $MMED $NUMI $SHRM $RVV $NLB $HOLL $WUHN $MOTA and more. https://psilocybinalpha.com/psychedelic-stock-watchlist https://psilocybinalpha.com/psychedelic-stock-watchlist"
[X Link](https://x.com/Psyched_Alpha/status/1264542133064732674) 2020-05-24T13:01Z 20.4K followers, [--] engagements
"Free Event co-hosted by the Canadian Securities Exchange: Investing in Psychedelics Participants include: Field Trip MindLeap BrightMinds Champignon $SHRM Revive $RVV Hollister $HOLL and more. Register here: https://www.eventbrite.ca/e/investing-in-psychedelics-tickets-105591250272utm_campaign=new_attendee&utm_medium=email&utm_source=eb_email&utm_term=event_name https://www.eventbrite.ca/e/investing-in-psychedelics-tickets-105591250272utm_campaign=new_attendee&utm_medium=email&utm_source=eb_email&utm_term=event_name"
[X Link](https://x.com/Psyched_Alpha/status/1264564794994184200) 2020-05-24T14:31Z 20.4K followers, [--] engagements
"NewLeaf Brands' latest Advisor has "extensive knowledge for treating people with homeopathic medicine." Does this bring confusion to the psychedelic medicine space conflating substances like psilocybin with homeopathy $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-announces-advisor-appointee-dr-aubrey-oliver-to-spearhead-jamaican-based-psilocybin-retreat-efforts https://psilocybinalpha.com/news/newleaf-announces-advisor-appointee-dr-aubrey-oliver-to-spearhead-jamaican-based-psilocybin-retreat-efforts"
[X Link](https://x.com/Psyched_Alpha/status/1265267190124744704) 2020-05-26T13:03Z 20.3K followers, [--] engagements
"NewLeaf Brands provides recap of Company developments. $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-brands-provides-an-update-to-its-shareholders-on-recent-corporate-developments-and-shares-a-positive-outlook https://psilocybinalpha.com/news/newleaf-brands-provides-an-update-to-its-shareholders-on-recent-corporate-developments-and-shares-a-positive-outlook"
[X Link](https://x.com/Psyched_Alpha/status/1265934053229936645) 2020-05-28T09:12Z 20.3K followers, [--] engagements
"NewLeaf Brands Name Change: NewLeaf Brands Inc. β‘ Mydecine Innovations Group Inc. NLB β‘ MYCO $NLB $NLBIF $MYCO https://psilocybinalpha.com/news/newleaf-brands-announces-name-and-stock-ticker-symbol-change-to-mydecine-innovations-group-inc-cse-myco https://psilocybinalpha.com/news/newleaf-brands-announces-name-and-stock-ticker-symbol-change-to-mydecine-innovations-group-inc-cse-myco"
[X Link](https://x.com/Psyched_Alpha/status/1267420537871052802) 2020-06-01T11:39Z 20.3K followers, [--] engagements
"NewLeaf (soon to be Mydecine) announces move into [----] sqft mycology R&D lab in Denver Colorado. $NLB $NLBIF $MYCO https://psilocybinalpha.com/news/newleaf-brands-announces-its-move-into-state-of-the-art-7500-sq-ft-specialty-mycology-rd-and-product-development-lab-in-denver-colorado https://psilocybinalpha.com/news/newleaf-brands-announces-its-move-into-state-of-the-art-7500-sq-ft-specialty-mycology-rd-and-product-development-lab-in-denver-colorado"
[X Link](https://x.com/Psyched_Alpha/status/1267780205504073733) 2020-06-02T11:28Z 20.3K followers, [--] engagements
"New Public Company Enters the Psychedelic Sector GreenStar Biosciences ( $GSTR ) is to acquire Toronto-based Eleusian Biosciences which has filed a provisional patent application in the US for psilocybin and N-Acetylcysteine combination therapy. https://psilocybinalpha.com/news/greenstar-biosciences-signs-agreement-to-acquire-100-of-eleusian-biosciences-corp https://psilocybinalpha.com/news/greenstar-biosciences-signs-agreement-to-acquire-100-of-eleusian-biosciences-corp"
[X Link](https://x.com/Psyched_Alpha/status/1272950561231552512) 2020-06-16T17:53Z 20.6K followers, [--] engagements
"We strive to keep our directory of psychedelic stocks updated. We just added GreenStar Biosciences ( $GSTR ) following the announcement that they are to acquire Eleusian Biosciences. Full resource here: https://psilocybinalpha.com/psilocybin-stocks-shroom-stocks https://psilocybinalpha.com/psilocybin-stocks-shroom-stocks"
[X Link](https://x.com/Psyched_Alpha/status/1272952925703340034) 2020-06-16T18:03Z 20.5K followers, [--] engagements
"We spoke to @GreenstarBio and @EleusianBio following yesterday's acquisition announcement. $GSTR https://psilocybinalpha.com/news/interview-with-greenstar-biosciences-and-eleusian-biosciences-following-acquisition-announcement https://psilocybinalpha.com/news/interview-with-greenstar-biosciences-and-eleusian-biosciences-following-acquisition-announcement"
[X Link](https://x.com/Psyched_Alpha/status/1273364431238574080) 2020-06-17T21:18Z 20.5K followers, [--] engagements
"This week we learned of [--] psychedelic companies that are going public: π Field Trip π Silo Wellness π Eleusian Biosciences"
[X Link](https://x.com/Psyched_Alpha/status/1274066852155723776) 2020-06-19T19:49Z 20K followers, [--] engagements
"The US OTC ticker for Numinus appears to have changed to $LKYSF (previously $LKYSD) Readers who are having trouble executing orders via TD Ameritrade for example may wish to try using LKYSF. $NUMI"
[X Link](https://x.com/Psyched_Alpha/status/1275185383161110529) 2020-06-22T21:54Z 20.3K followers, [--] engagements
"π¦Private Financing Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-announces-private-placement-financing-of-up-to-1-5-million https://psilocybinalpha.com/news/hollister-biosciences-inc-announces-private-placement-financing-of-up-to-1-5-million"
[X Link](https://x.com/Psyched_Alpha/status/1278805573832790016) 2020-07-02T21:39Z 20.5K followers, [--] engagements
"Hollister Biosciences' private placement: $0.085 per share Warrants @ $0.10 for [--] months $HOLL currently trading at $0.11"
[X Link](https://x.com/Psyched_Alpha/status/1278807541972164608) 2020-07-02T21:47Z 20.4K followers, [--] engagements
"You can now browse the latest news by Company name. $NUMI $SHRM $MMED $TRIP $BUZZ $MYCO $RVV $HOLL and more. Try it here: https://psilocybinalpha.com/news https://psilocybinalpha.com/news"
[X Link](https://x.com/Psyched_Alpha/status/1284566181374984192) 2020-07-18T19:10Z 20.4K followers, [--] engagements
"π° GreenStar Biosciences Acquires Eleusian Biosciences Eleusian is acquired by GreenStar for approximately $3m via common share issuance. Transaction expected to close by August [--]. $GSTR $GTSIF https://psilocybinalpha.com/news/greenstar-biosciences-signs-definitive-agreement-to-acquire-100-of-eleusian-biosciences-corp https://psilocybinalpha.com/news/greenstar-biosciences-signs-definitive-agreement-to-acquire-100-of-eleusian-biosciences-corp"
[X Link](https://x.com/Psyched_Alpha/status/1285665356414164992) 2020-07-21T19:58Z 20.6K followers, [--] engagements
"GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences $GSTR $GTSIF https://psilocybinalpha.com/news/greenstar-biosciences-announces-filing-of-third-provisional-patent-application-by-eleusian-biosciences https://psilocybinalpha.com/news/greenstar-biosciences-announces-filing-of-third-provisional-patent-application-by-eleusian-biosciences"
[X Link](https://x.com/Psyched_Alpha/status/1286658124338864128) 2020-07-24T13:42Z 20.5K followers, [--] engagements
"π° Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing The Company sold 17.6mm units at a price of $0.085 each for gross proceeds of approx. $1.5mm. The current stock price of HOLL is $0.14. $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-closes-1-5-million-private-placement-financing https://psilocybinalpha.com/news/hollister-biosciences-inc-closes-1-5-million-private-placement-financing"
[X Link](https://x.com/Psyched_Alpha/status/1293107636934791168) 2020-08-11T08:51Z 20.5K followers, [--] engagements
"Hollister Biosciences Inc. Reports Second Quarter [----] Results Net income for the three-month period ended June 30th [----] was $0.3 million compared to a net loss of $2.1 million in the first quarter of [----] $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-reports-second-quarter-2020-results https://psilocybinalpha.com/news/hollister-biosciences-inc-reports-second-quarter-2020-results"
[X Link](https://x.com/Psyched_Alpha/status/1297869751646130176) 2020-08-24T12:13Z 20.5K followers, [--] engagements
"Hollister Biosciences Retains Renmark Financial Communications Inc. to handle its investor relations activities. $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-retains-renmark-financial-communications-inc https://psilocybinalpha.com/news/hollister-biosciences-retains-renmark-financial-communications-inc"
[X Link](https://x.com/Psyched_Alpha/status/1304554928883499013) 2020-09-11T22:58Z 20.5K followers, [--] engagements
"Today's gainers: $CMPS +10.4% $HOLL +10% $FTRP +9.1% $NUMI +2.9%"
[X Link](https://x.com/Psyched_Alpha/status/1316139145773936640) 2020-10-13T22:09Z 20.4K followers, [--] engagements
"Our Weekly Psychedelics Bulletin MindMed raises $28.75m Entheon inches closer to go-public next Tuesday sees voters decide on decriminalisation in two US states. Including news from: $MMED $FTRP $SHRM $HAVN $HOLL https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-raises-28-75m-entheon-inches-closer-to-go-public-next-weeks-votes-on-decriminalisation https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-raises-28-75m-entheon-inches-closer-to-go-public-next-weeks-votes-on-decriminalisation"
[X Link](https://x.com/Psyched_Alpha/status/1322281203051962371) 2020-10-30T20:56Z 20.4K followers, [--] engagements
"Champignon Brands Announces New CFO and New General Counsel $SHRM $SHRMF https://psilocybinalpha.com/news/champignon-brands-announces-new-cfo-and-new-general-counsel https://psilocybinalpha.com/news/champignon-brands-announces-new-cfo-and-new-general-counsel"
[X Link](https://x.com/Psyched_Alpha/status/1348614081499045889) 2021-01-11T12:53Z 20.3K followers, [--] engagements
"A strong day for most psychedelics stocks. $CMPS +0.3% $MMED +11.4% $NUMI +14.1% $SHRMF -1.7% $CYBN -5.4% $FTRP +5.1% $MYCO +3.8% $HAVN +7.9% $ENBI +20.2% $TRYP +9.9%"
[X Link](https://x.com/Psyched_Alpha/status/1352398490199011336) 2021-01-21T23:31Z 20.3K followers, [--] engagements
"Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression $SHRM $SHRMF https://psilocybinalpha.com/news/champignon-brands-canadian-rapid-treatment-center-of-excellence-opens-first-community-based-centre-in-ottawa-to-provide-ketamine-treatment-for-adults-with-depression https://psilocybinalpha.com/news/champignon-brands-canadian-rapid-treatment-center-of-excellence-opens-first-community-based-centre-in-ottawa-to-provide-ketamine-treatment-for-adults-with-depression"
[X Link](https://x.com/Psyched_Alpha/status/1353687680513699842) 2021-01-25T12:54Z 20.3K followers, [--] engagements
"Psychedelics Stock Top Gainers - Feb 16th [----] $TRYP +21.2% $LOBE +13.3% $NEON +7.6% $ENBI +6.2% $MMED +4.9% $NUMI +3.9% $FTRP +3.1% $HAVN +3.0% $SHRMF +2.7%"
[X Link](https://x.com/Psyched_Alpha/status/1361809126704222208) 2021-02-16T22:46Z 20.3K followers, [--] engagements
"PsyBio Completes Reverse Take-Over Transaction Expected to list on the TSXV under ticker symbol $PSYB. https://psilocybinalpha.com/news/psybio-completes-reverse-take-over-transaction https://psilocybinalpha.com/news/psybio-completes-reverse-take-over-transaction"
[X Link](https://x.com/Psyched_Alpha/status/1362868083497517056) 2021-02-19T20:54Z 20.3K followers, [--] engagements
"Your Weekly Psychedelic Bulletin - Field Trip raising $83m - NYU Langone Officially Launches Psychedelic Medicine Center - MDMA for Alcohol Use Disorder; DMT for Kidney Transplant - and more inc. news from $FTRP $MMED $PSYB $NOVA $MSET $TRIP https://psilocybinalpha.com/news/psychedelic-bulletin-field-trip-raising-83m-nyu-langone-launches-psychedelic-medicine-center-the-many-applications-of-dmt https://psilocybinalpha.com/news/psychedelic-bulletin-field-trip-raising-83m-nyu-langone-launches-psychedelic-medicine-center-the-many-applications-of-dmt"
[X Link](https://x.com/Psyched_Alpha/status/1365421934964523013) 2021-02-26T22:02Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research Development and Manufacturing Organization https://psilocybinalpha.com/news/psybio-therapeutics-initiates-pilot-scale-development-of-proprietary-biosynthetic-psilocybin-with-global-contract-research-development-and-manufacturing-organization https://psilocybinalpha.com/news/psybio-therapeutics-initiates-pilot-scale-development-of-proprietary-biosynthetic-psilocybin-with-global-contract-research-development-and-manufacturing-organization"
[X Link](https://x.com/Psyched_Alpha/status/1366746580368453635) 2021-03-02T13:45Z 20.3K followers, [--] engagements
"Psychedelic Stocks Performance 9th March [----] $PSYK +7.7% $CMPS +12% $MMED +3.4% $NUMI +3.8% $SHRMF +5.7% $CYBN +.69% $FTRP +9.7% $MYCO +6.1% $HAVN +8.5%"
[X Link](https://x.com/Psyched_Alpha/status/1369398178513117188) 2021-03-09T21:22Z 20.3K followers, [--] engagements
"Champignon Brands stock is up 75% on its re-commencing of trading on the CSE today. $SHRM $SHRMF"
[X Link](https://x.com/Psyched_Alpha/status/1385619062647148546) 2021-04-23T15:38Z 20.3K followers, [--] engagements
"Psychedelic Bulletin 23rd April [----] MindMed $MMED to list on the Nasdaq Atai Life Sciences to IPO Champignon Brands $SHRM $SHRMF Resumes Trading . and more from $RVV $CYBN $PHRM https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-to-list-on-nasdaq-atai-ipo-unveiled-champignon-brands-resumes-trading https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-to-list-on-nasdaq-atai-ipo-unveiled-champignon-brands-resumes-trading"
[X Link](https://x.com/Psyched_Alpha/status/1385639646059708418) 2021-04-23T17:00Z 20.3K followers, [--] engagements
"PsyBio $PSYB and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform Expediting its IND Submission to the FDA https://psilocybinalpha.com/news/psybio-and-miami-university-broaden-partnership-agreement-for-the-continued-advancement-of-its-neuropsychiatric-drug-discovery-platform-expediting-its-ind-submission-to-the-fda"
[X Link](https://x.com/Psyched_Alpha/status/1386750274077970433) 2021-04-26T18:33Z 20.3K followers, [--] engagements
"π MindMed Nasdaq Listing Poll MindMed lists on the Nasdaq today under ticker symbol $MNMD. What price will it close at $MMED $MMEDF $5 $5-$7.5 $10 $7.51 - $10 $5 $5-$7.5 $10 $7.51 - $10"
[X Link](https://x.com/Psyched_Alpha/status/1386996288252751872) 2021-04-27T10:50Z 20.3K followers, [--] engagements
"Entheon Biomedical Lists on OTCQB Venture Market under $ENTBF https://psilocybinalpha.com/news/entheon-biomedical-lists-on-otcqb-venture-market https://psilocybinalpha.com/news/entheon-biomedical-lists-on-otcqb-venture-market"
[X Link](https://x.com/Psyched_Alpha/status/1389960790963376128) 2021-05-05T15:10Z 20.3K followers, [--] engagements
"Wesana Health Commences Trading on the CSE Ticker symbol $WESA https://psilocybinalpha.com/news/wesana-health-commences-trading-on-the-cse https://psilocybinalpha.com/news/wesana-health-commences-trading-on-the-cse"
[X Link](https://x.com/Psyched_Alpha/status/1391721020822802434) 2021-05-10T11:45Z 20.6K followers, [--] engagements
"Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market $FTRP $FTRPF https://psilocybinalpha.com/news/field-trip-health-ltd-applies-to-list-its-common-shares-on-the-nasdaq-stock-market https://psilocybinalpha.com/news/field-trip-health-ltd-applies-to-list-its-common-shares-on-the-nasdaq-stock-market"
[X Link](https://x.com/Psyched_Alpha/status/1402238631285243912) 2021-06-08T12:18Z 20.3K followers, [--] engagements
"MindMed Appoints Pharmaceutical Veteran Peter Bergethon M.D. to Scientific Advisory Board Dr. Bergethon is the Vice President and Head of Digital and Quantitative Medicine at Biogen Inc. $MMED $MNMD https://psilocybinalpha.com/news/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-m-d-to-scientific-advisory-board https://psilocybinalpha.com/news/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-m-d-to-scientific-advisory-board"
[X Link](https://x.com/Psyched_Alpha/status/1405490818065092613) 2021-06-17T11:41Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Subsidiary HaluGen Life Sciences Announces Agreement with Third Wave https://psilocybinalpha.com/news/entheon-biomedical-subsidiary-halugen-life-sciences-announces-agreement-with-third-wave https://psilocybinalpha.com/news/entheon-biomedical-subsidiary-halugen-life-sciences-announces-agreement-with-third-wave"
[X Link](https://x.com/Psyched_Alpha/status/1407333381021573124) 2021-06-22T13:43Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds including Psilocybin with France-based Biose Industrie https://psilocybinalpha.com/news/psybio-therapeutics-initiates-european-manufacturing-of-proprietary-biosynthetic-psychedelic-compounds-including-psilocybin-with-france-based-biose-industrie https://psilocybinalpha.com/news/psybio-therapeutics-initiates-european-manufacturing-of-proprietary-biosynthetic-psychedelic-compounds-including-psilocybin-with-france-based-biose-industrie"
[X Link](https://x.com/Psyched_Alpha/status/1407393447376527362) 2021-06-22T17:42Z 20.3K followers, [--] engagements
"Entheon Biomedical Corp. $ENBI Acquires Lobo Genetics Inc. Company acquires second genetic screening asset. https://psilocybinalpha.com/news/entheon-biomedical-corp-acquires-lobo-genetics-inc https://psilocybinalpha.com/news/entheon-biomedical-corp-acquires-lobo-genetics-inc"
[X Link](https://x.com/Psyched_Alpha/status/1421080711017205763) 2021-07-30T12:10Z 20.3K followers, [--] engagements
"Psychedelics Bulletin July [--] [----] MindMed initiates DMT trial $MNMD ( $DMT $ATAI and $ENBI also exploring DMT) COMPASS Pathways appoints CMO $CMPS Field Trip lists on NASDAQ $FTRP . and more. https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-initiates-dmt-trial-compass-appoints-cmo-field-trip-lists-on-nasdaq https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-initiates-dmt-trial-compass-appoints-cmo-field-trip-lists-on-nasdaq"
[X Link](https://x.com/Psyched_Alpha/status/1421168101425655808) 2021-07-30T17:57Z 20.3K followers, [--] engagements
"PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs $PSYB https://psilocybinalpha.com/news/psybio-therapeutics-files-patent-application-with-uspto-for-production-methods-of-methylated-trypatamines-and-associated-analogs https://psilocybinalpha.com/news/psybio-therapeutics-files-patent-application-with-uspto-for-production-methods-of-methylated-trypatamines-and-associated-analogs"
[X Link](https://x.com/Psyched_Alpha/status/1427338834031824898) 2021-08-16T18:37Z 20.3K followers, [--] engagements
"Charles Nichols on HaluGen's (Entheon subsidiary $ENBI) psychedelics genetic test: The premise of trying to link one polymorphism with a behavioral predictor is just I would say preposterous. https://www.vice.com/en/article/y3d4xb/genetic-testing-predict-bad-psychedelic-trip-halugen https://www.vice.com/en/article/y3d4xb/genetic-testing-predict-bad-psychedelic-trip-halugen"
[X Link](https://x.com/Psyched_Alpha/status/1428715488356540418) 2021-08-20T13:48Z 20.3K followers, [--] engagements
"#Psychedelics Bulletin August [--] [----] Beckley Psytech raises $80m in Series B round Bright Minds $DRUG share positive preclinical findings HaluGen's psychedelics DNA test called into question $ENBI . and more. https://psilocybinalpha.com/news/psychedelic-bulletin-beckley-psytech-raises-80m-in-series-b-bright-minds-biosciences-reports-positive-preclinical-findings-psychedelics-dna-test-called-into-question"
[X Link](https://x.com/Psyched_Alpha/status/1428807890714906630) 2021-08-20T19:55Z 20.3K followers, [--] engagements
"Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon $ENBI Advisory Board "Dr. David Erritzoe to provide guidance on psychopharmacological research" https://psilocybinalpha.com/news/clinical-director-of-imperial-colleges-center-for-psychedelic-research-joins-entheon-advisory-board https://psilocybinalpha.com/news/clinical-director-of-imperial-colleges-center-for-psychedelic-research-joins-entheon-advisory-board"
[X Link](https://x.com/Psyched_Alpha/status/1430509052480692225) 2021-08-25T12:35Z 20.3K followers, [--] engagements
"Wesana Health $WESA Announces Closing of PsyTech Acquisition https://psilocybinalpha.com/news/wesana-health-announces-closing-of-psytech-acquisition https://psilocybinalpha.com/news/wesana-health-announces-closing-of-psytech-acquisition"
[X Link](https://x.com/Psyched_Alpha/status/1435974270992142342) 2021-09-09T14:31Z 20.6K followers, [--] engagements
"Citigroup Top Stock Picks Range From Psychedelic Drugs to NFTs The bank's Disruptive Innovations report included psychedelics citing $ATAI and $CMPS in particular. https://www.bloomberg.com/news/articles/2021-10-12/citigroup-turns-to-psychedelic-drugs-nfts-for-investment-picks https://www.bloomberg.com/news/articles/2021-10-12/citigroup-turns-to-psychedelic-drugs-nfts-for-investment-picks"
[X Link](https://x.com/Psyched_Alpha/status/1447959352661446662) 2021-10-12T16:16Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Provides Corporate Update on Studies and Clinical Trials https://psilocybinalpha.com/news/entheon-biomedical-provides-corporate-update-on-studies-and-clinical-trials https://psilocybinalpha.com/news/entheon-biomedical-provides-corporate-update-on-studies-and-clinical-trials"
[X Link](https://x.com/Psyched_Alpha/status/1453344664967319553) 2021-10-27T12:55Z 20.3K followers, [--] engagements
"Psychedelics Bulletin Oct [--] [----] MindMed announces R(-)-MDMA program Psilocybin for anxiety study secures ethics approval UCL joins the renaissance: @PsychedelicUNIT + more from: $CYBN $DMT $MYND $SILO $AWKN $ENBI $MCUR $MYCO $NOVA $PHRM https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-announces-r-mdma-program-psilocybin-for-anxiety-study-secures-ethics-approval-ucl-joins-the-renaissance https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-announces-r-mdma-program-psilocybin-for-anxiety-study-secures-ethics-approval-ucl-joins-the-renaissance"
[X Link](https://x.com/Psyched_Alpha/status/1454173606246850563) 2021-10-29T19:49Z 20.3K followers, [--] engagements
"Numinus OTC Ticker Change $LKYSF - $NUMIF https://psilocybinalpha.com/news/numinus-to-begin-trading-on-the-otc-under-symbol-numif https://psilocybinalpha.com/news/numinus-to-begin-trading-on-the-otc-under-symbol-numif"
[X Link](https://x.com/Psyched_Alpha/status/1461689881063739405) 2021-11-19T13:36Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications "Intellectual Property Filing and Protection Remains a Top Priority" https://psilocybinalpha.com/news/psybio-therapeutics-furthers-intellectual-property-portfolio-with-six-new-manufacturing-patent-applications https://psilocybinalpha.com/news/psybio-therapeutics-furthers-intellectual-property-portfolio-with-six-new-manufacturing-patent-applications"
[X Link](https://x.com/Psyched_Alpha/status/1461749134818521095) 2021-11-19T17:32Z 20.3K followers, [--] engagements
"Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences Participants Receive First Doses of Psilocybin $BRAX https://psilocybinalpha.com/news/braxia-scientific-achieves-milestone-as-landmark-psilocybin-clinical-trial-commences-participants-receive-first-doses-of-psilocybin https://psilocybinalpha.com/news/braxia-scientific-achieves-milestone-as-landmark-psilocybin-clinical-trial-commences-participants-receive-first-doses-of-psilocybin"
[X Link](https://x.com/Psyched_Alpha/status/1470742310354919427) 2021-12-14T13:07Z 20.3K followers, [--] engagements
"Entheon Biomedical $ENBI Announces Expanded Psychedelics Genetic Test Panel "Subsidiary HaluGen Life Sciences has expanded its genetic test panel to include the CYP2D6 gene a marker indicating the metabolism of LSD MDMA and ayahuasca" https://psilocybinalpha.com/news/entheon-biomedical-announces-expanded-psychedelics-genetic-test-panel https://psilocybinalpha.com/news/entheon-biomedical-announces-expanded-psychedelics-genetic-test-panel"
[X Link](https://x.com/Psyched_Alpha/status/1473604433904914437) 2021-12-22T10:40Z 20.3K followers, [--] engagements
"Entheon Biomedical $ENBI Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee https://psilocybinalpha.com/news/entheon-biomedical-provides-update-on-dmt-human-trial-and-announces-regulatory-submission-to-ethics-committee https://psilocybinalpha.com/news/entheon-biomedical-provides-update-on-dmt-human-trial-and-announces-regulatory-submission-to-ethics-committee"
[X Link](https://x.com/Psyched_Alpha/status/1479094654285099011) 2022-01-06T14:17Z 20.3K followers, [--] engagements
"Wesana Health Granted US FDA Pre-IND Meeting for SANA-013 $WESA https://psilocybinalpha.com/news/wesana-health-granted-us-fda-pre-ind-meeting-for-sana-013 https://psilocybinalpha.com/news/wesana-health-granted-us-fda-pre-ind-meeting-for-sana-013"
[X Link](https://x.com/Psyched_Alpha/status/1480893493643993089) 2022-01-11T13:24Z 20.6K followers, [--] engagements
"Wesana Health $WESA Provides Strategic and Operational Updates https://psilocybinalpha.com/news/wesana-health-provides-strategic-and-operational-updates https://psilocybinalpha.com/news/wesana-health-provides-strategic-and-operational-updates"
[X Link](https://x.com/Psyched_Alpha/status/1481255909045198852) 2022-01-12T13:25Z 20.6K followers, [--] engagements
"BC Craft Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada) Are we starting to see bankruptcy proceedings of the first few loosely-defined psychedelics company https://www.globenewswire.com/news-release/2022/01/25/2373047/0/en/BC-Craft-Has-Filed-Notice-of-Intention-to-Make-a-Proposal-Under-the-Bankruptcy-Insolvency-Act-Canada.html https://www.globenewswire.com/news-release/2022/01/25/2373047/0/en/BC-Craft-Has-Filed-Notice-of-Intention-to-Make-a-Proposal-Under-the-Bankruptcy-Insolvency-Act-Canada.html"
[X Link](https://x.com/Psyched_Alpha/status/1486326155376574467) 2022-01-26T13:12Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Partners with Wavepaths on Upcoming Observational Study Study is taking place at Heading Health. https://psilocybinalpha.com/news/entheon-biomedical-partners-with-wavepaths-on-upcoming-observational-study https://psilocybinalpha.com/news/entheon-biomedical-partners-with-wavepaths-on-upcoming-observational-study"
[X Link](https://x.com/Psyched_Alpha/status/1493941595615416325) 2022-02-16T13:33Z 20.3K followers, [--] engagements
"Entheon Biomedical Announces Non-Brokered Private Placement Financing Units priced at C$0.10 for gross proceeds up to C$3m $ENBI which was trading at C$0.18 this time last month today trades at C$0.12 walking down toward the offering price. https://psilocybinalpha.com/news/entheon-biomedical-announces-non-brokered-private-placement-financing https://psilocybinalpha.com/news/entheon-biomedical-announces-non-brokered-private-placement-financing"
[X Link](https://x.com/Psyched_Alpha/status/1511384372892549134) 2022-04-05T16:44Z 20.3K followers, [--] engagements
"Cybin Acquires DMT Clinical Study from Entheon Biomedical $CYBN has acquired a Phase [--] DMT study from $ENBI. "The Phase [--] EBRX-101 study now named CYB004-E is being conducted in the Netherlands at the Centre for Human Drug Research." https://www.businesswire.com/news/home/20220606006028/en/ https://www.businesswire.com/news/home/20220606006028/en/"
[X Link](https://x.com/Psyched_Alpha/status/1534151903248015361) 2022-06-07T12:34Z 20.3K followers, [--] engagements
"Psychedelic Bulletin #119 π More Misery for MindMed $MNMD π¦ Onsero Looks to Skip the Trip β No Safe $HAVN: Another Psychedelics Company Grinds to a Halt β An Update on Terran vs Compass $CMPS π A Very Brief Dispatch from ICPR & more. https://psychedelicalpha.com/news/psychedelic-bulletin-119-more-misery-for-mindmed-another-psychedelics-co-ceases-operations-a-brief-dispatch-from-icpr https://psychedelicalpha.com/news/psychedelic-bulletin-119-more-misery-for-mindmed-another-psychedelics-co-ceases-operations-a-brief-dispatch-from-icpr"
[X Link](https://x.com/Psyched_Alpha/status/1575989023977271297) 2022-09-30T23:20Z 20.3K followers, [--] engagements
"Half of All Public Psychedelics Companies at Risk of Running out of Cash This Year According to our data 1/2 have already run out of cash or are set to do so by the end of [----]. Unless financings take place or cash burn slows significantly it's the end of the road"
[X Link](https://x.com/Psyched_Alpha/status/1585655714688765952) 2022-10-27T15:32Z 20.3K followers, [--] engagements
""Field Trip Health will be offering their services free of charge to people who got laid off from a host of companiesincluding Twitter Meta Stripe and others." $FTHW https://fortune.com/well/2022/11/30/laid-off-workers-free-ketamine-assisted-therapy-services-field-trip/ https://fortune.com/well/2022/11/30/laid-off-workers-free-ketamine-assisted-therapy-services-field-trip/"
[X Link](https://x.com/Psyched_Alpha/status/1597996196953722880) 2022-11-30T16:49Z 20.3K followers, [--] engagements
"Numinus $NUMI Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea Trainee therapists will ingest tea brewed with whole Psilocybe mushrooms. https://psychedelicalpha.com/news/numinus-receives-clinical-trial-application-approval-from-health-canada-for-experiential-psychedelic-assisted-therapy-training-using-psilocybe-cubensis-tea"
[X Link](https://x.com/Psyched_Alpha/status/1620811391358861313) 2023-02-01T15:48Z 20K followers, [---] engagements
"BREAKING: Reunion Neuroscience Files Lawsuit Against Mindset Pharma $REUN alleges that $MSET knowingly copied Reunions RE104 compound and misleadingly presented that exact composition while applying for U.S. Patent No. [--------] https://psychedelicalpha.com/news/reunion-neuroscience-files-lawsuit-against-mindset-pharma https://psychedelicalpha.com/news/reunion-neuroscience-files-lawsuit-against-mindset-pharma"
[X Link](https://x.com/Psyched_Alpha/status/1635415924210794497) 2023-03-13T23:01Z 20.3K followers, [----] engagements
"FT: US clinic offers ketamine therapy to treat alcoholism "UK biotech Awakn licences party drug to addiction clinics" $AWKN https://www.ft.com/content/2d142cff-1a92-4652-b2d7-86c29ab9566c https://www.ft.com/content/2d142cff-1a92-4652-b2d7-86c29ab9566c"
[X Link](https://x.com/Psyched_Alpha/status/1635729936882466817) 2023-03-14T19:49Z 20.3K followers, [----] engagements
"BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations Chicago Washington DC Seattle San Diego Fredericton "The anticipated last day of operation for each of these locations will be on or around April [--] 2023." $FTHW https://finance.yahoo.com/news/field-trip-health-wellness-close-125000229.html https://finance.yahoo.com/news/field-trip-health-wellness-close-125000229.html"
[X Link](https://x.com/Psyched_Alpha/status/1635998530526388229) 2023-03-15T13:36Z 20.3K followers, [----] engagements
"Field Trip Shutters Majority of its Clinics According to the company's most recent deck $FTHW operates [--] clinics in North America ("and growing"). The closure of these [--] locations which will happen in around a month represents the majority of its physical presence. BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations Chicago Washington DC Seattle San Diego Fredericton "The anticipated last day of operation for each of these locations will be on or around April [--] 2023." $FTHW https://t.co/bKypWL4MCx BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations"
[X Link](https://x.com/Psyched_Alpha/status/1636000552763940864) 2023-03-15T13:45Z 20.3K followers, [----] engagements
"Analysis: Reunion Neuroscience Sues Mindset Pharma Claims it Copied RE104 Inside: π
A timeline of key events β The strength (or lack thereof) of $REUN's lawsuit against $MSET πΊ Broader context Will this lawsuit lead to a reunion with karma https://psychedelicalpha.com/news/reunion-sues-mindset-claims-it-copied-re104 https://psychedelicalpha.com/news/reunion-sues-mindset-claims-it-copied-re104"
[X Link](https://x.com/Psyched_Alpha/status/1636068984394076160) 2023-03-15T18:16Z 20.3K followers, [----] engagements
"Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery $WESA's SANA-13 is a combination of psilocybin and cannabidiol. Sale to $LSDI expected to complete in Q2. https://psychedelicalpha.com/news/wesana-health-announces-sale-of-sana-13-assets-to-lucy-scientific-discovery https://psychedelicalpha.com/news/wesana-health-announces-sale-of-sana-13-assets-to-lucy-scientific-discovery"
[X Link](https://x.com/Psyched_Alpha/status/1638223175321280512) 2023-03-21T16:56Z 20.3K followers, [---] engagements
"Update: Field Trip Shares Suspended Trading CEO Resigns CEO and co-founder Ronan Levy has resigned replaced by a Chief Restructuring Officer. Field Trip has obtained creditor protection under the CCAA. Trading of $FTHW has been suspended. https://psychedelicalpha.com/news/field-trip-health-wellness-obtains-ccaa-protection Field Trip Shutters Majority of its Clinics According to the company's most recent deck $FTHW operates [--] clinics in North America ("and growing"). The closure of these [--] locations which will happen in around a month represents the majority of its physical presence."
[X Link](https://x.com/Psyched_Alpha/status/1638635205111029760) 2023-03-22T20:14Z 20.3K followers, 20.8K engagements
"Field Trips Downfall: Too Early Too Aggressive Too Extravagant We dig through pitch decks interviews and data to piece together a trip report that saw Field Trip $FTHW go from loud brash market leader to all-but bankrupt. https://psychedelicalpha.com/news/field-trips-downfall-too-early-too-aggressive-too-extravagant https://psychedelicalpha.com/news/field-trips-downfall-too-early-too-aggressive-too-extravagant"
[X Link](https://x.com/Psyched_Alpha/status/1640724621652549639) 2023-03-28T14:36Z 20.3K followers, [--] engagements
"Are psychedelic medicines the reset for chronic pain "Psychedelics may improve functionality and quality of life in chronic pain patients." "The therapeutic potential of psychedelics for chronic pain warrants expanded research." https://www.sciencedirect.com/science/article/abs/pii/S0028390823001181via%3Dihub https://www.sciencedirect.com/science/article/abs/pii/S0028390823001181via%3Dihub"
[X Link](https://x.com/Psyched_Alpha/status/1643574852018733056) 2023-04-05T11:22Z 20.3K followers, [----] engagements
"Awakn $AWKN Provides Corporate Update Among the updates: Dr. Ben Sessa has resigned from his role as Head of Psychedelic Medicine at Awakn. https://www.newsfilecorp.com/release/162112/Awakn-Life-Sciences-Increases-Ownership-of-Awakn-Bristol-to-100-and-Provides-Corporate-Update https://www.newsfilecorp.com/release/162112/Awakn-Life-Sciences-Increases-Ownership-of-Awakn-Bristol-to-100-and-Provides-Corporate-Update"
[X Link](https://x.com/Psyched_Alpha/status/1646177170425880576) 2023-04-12T15:43Z 20.3K followers, [---] engagements
"Psychedelic Bulletin #139 π Paper Claims Psychedelics Exert Antidepressant Effects By Binding to TrkB Not 5-HT2A π΅ $42 Million for Ibogaine Research π Reunion $REUN Announces Take-Private Transaction π§ $CMPS Patents Upheld and more. https://psychedelicalpha.com/news/psychedelic-bulletin-139-kentucky-earmarks-42m-for-ibogaine-studies-reunion-announces-take-private-deal-compass-patents-upheld-theories-of-psychedelics-mechanism-of-action"
[X Link](https://x.com/Psyched_Alpha/status/1669097816533221376) 2023-06-14T21:41Z 20.3K followers, [---] engagements
"The recent legalisation of psychedelic-assisted therapy for post-traumatic stress disorder and treatment-resistant depression has the potential of providing people with an alternative means of care at the end of our lives"
[X Link](https://x.com/Psyched_Alpha/status/1678702466420932608) 2023-07-11T09:49Z 19.5K followers, [---] engagements
"Legalizing psychedelics could become a ballot question in Massachusetts "Massachusetts has the opportunity to lead the way in the mental health revolution" Southwick Republican Rep. Nicholas Boldyga told his colleagues"
[X Link](https://x.com/Psyched_Alpha/status/1678766447139618816) 2023-07-11T14:10Z 19.4K followers, [---] engagements
"Do psychedelics treat chronic pain or is it the placebo effect "Preliminary studies show that psilocybin a compound in magic mushrooms reduces pain in people with chronic Lyme disease fibromyalgia and migraines." https://www.newscientist.com/article/2381495-do-psychedelics-treat-chronic-pain-or-is-it-the-placebo-effect/ https://www.newscientist.com/article/2381495-do-psychedelics-treat-chronic-pain-or-is-it-the-placebo-effect/"
[X Link](https://x.com/Psyched_Alpha/status/1679146909800300544) 2023-07-12T15:13Z 20.3K followers, [----] engagements
""Last year Dr. Bronners released a midterm voter guide with a list of [--] state and local ballot initiatives the company felt strongly about such as decriminalizing psychedelics and increasing taxes on the rich.""
[X Link](https://x.com/Psyched_Alpha/status/1679203539568959489) 2023-07-12T19:03Z 19.5K followers, 11.7K engagements
"House poised to OK psychedelics for military trauma thanks to Crenshaw-AOC partnership "The ex-Navy SEAL from Houston and Ocasio-Cortez a New York democratic socialist extol psilocybin to treat PTSD depression and addiction.""
[X Link](https://x.com/Psyched_Alpha/status/1679832981186248705) 2023-07-14T15:55Z 19.4K followers, [----] engagements
"Could psychedelics simultaneously treat chronic pain and depression ".undergraduate Ahmad Hammo is spending the summer alongside Joseph Cichon . investigating the potential for psilocybin to treat chronic neuropathic pain." https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression"
[X Link](https://x.com/Psyched_Alpha/status/1686307653985681409) 2023-08-01T09:27Z 20.3K followers, [----] engagements
"MindMed has secured a $50m credit facility $15m was drawn at closing. Together with $MNMD cash on hand the company expects to fund operations into [----]. https://www.businesswire.com/news/home/20230814596096/en/MindMed-Secures-50.0-Million-Credit-Facility-with-K2-HealthVentures https://www.businesswire.com/news/home/20230814596096/en/MindMed-Secures-50.0-Million-Credit-Facility-with-K2-HealthVentures"
[X Link](https://x.com/Psyched_Alpha/status/1691069447325331456) 2023-08-14T12:49Z 19.9K followers, [----] engagements
"Psychedelic drug therapy: Just say yes "CONGRESS WARMS TO PSYCHEDELIC DRUGS Psychedelic medicine is forging unexpected alliances in Washington.""
[X Link](https://x.com/Psyched_Alpha/status/1691094867596988417) 2023-08-14T14:30Z 19.4K followers, [----] engagements
"Psychedelics Are Reaching New Highs in Acceptance and Businesses Want In "Once seen as taboo psychedelics are being recognized for their medicinal potential in treating some mental health ailments." https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html"
[X Link](https://x.com/Psyched_Alpha/status/1691827990198386882) 2023-08-16T15:03Z 20K followers, [----] engagements
"Former Director of Strategy & Operations Brings Complaint Against MindMed The complaint alleges among other things that the company is a "boy's club" with Plaintiff Madeline Feldman withstanding "years of unequal pay and harassment""
[X Link](https://x.com/Psyched_Alpha/status/1695100999281656052) 2023-08-25T15:49Z 19.9K followers, [---] engagements
"Ottawa police shut down store selling illegal magic mushrooms in Centretown "Police say despite the execution of the warrant and notification from the property owner to cease any unlawful activity last Friday the store re-opened for business this week.""
[X Link](https://x.com/Psyched_Alpha/status/1695104033084567658) 2023-08-25T16:01Z 19.5K followers, [---] engagements
"BREAKING: Cybin to Acquire Small Pharma Inc. $CYBN will acquire $DMT in an all-share transaction"
[X Link](https://x.com/Psyched_Alpha/status/1696173794090537057) 2023-08-28T14:52Z 19.4K followers, [--] engagements
"BREAKING: Otsuka to Acquire Mindset Pharma $MSET"
[X Link](https://x.com/Psyched_Alpha/status/1697226014580003285) 2023-08-31T12:33Z 20.3K followers, [----] engagements
"Big Pharma Company Otsuka to Buy Mindset Pharma Toronto-based Mindset Pharma $MSET is set to be acquired by the U.S. arm of Otsuka Pharmaceutical in an all-cash transaction valued at around CAD $80m (around USD $60m). https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m"
[X Link](https://x.com/Psyched_Alpha/status/1697227748735889865) 2023-08-31T12:40Z 20.3K followers, [----] engagements
"How does psilocybin-assisted therapy work in Colorado and Oregon "Regulators are still crafting rules for Colorado but standards have emerged underground and in Oregon""
[X Link](https://x.com/Psyched_Alpha/status/1698656510308471163) 2023-09-04T11:17Z 19.4K followers, [---] engagements
"I cured my ARFID with psilocybin. I shouldnt have needed to self-treat it "In August I self-administered a therapeutic dose of psilocybin mushrooms and intentionally ate a dozen new-to-me foods during my psychedelic trip.""
[X Link](https://x.com/Psyched_Alpha/status/1699359441039003793) 2023-09-06T09:50Z 19.5K followers, [----] engagements
"California Assembly passes psychedelics decriminalization bill (SB 58) 43-15 vote Now returns to Senate for final sign-off before heading to the Governor's desk"
[X Link](https://x.com/Psyched_Alpha/status/1699699972990517710) 2023-09-07T08:23Z 19.2K followers, [----] engagements
"MindMed Sues $100 Million Meme Stock Trader Over Proxy Bid $MNMD alleges that Jake Freeman issued misleading proxy solicitations to shareholders. https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid"
[X Link](https://x.com/Psyched_Alpha/status/1700061418182038003) 2023-09-08T08:20Z 19.9K followers, [---] engagements
"VC Ford Smith used psychedelics and biohacking to pull himself out of a deep depression. "In the four years that he and his firm have been focusing on the industry Smith says he's been heartened by the uptick in interest""
[X Link](https://x.com/Psyched_Alpha/status/1700137206969516267) 2023-09-08T13:21Z 19.2K followers, [---] engagements
"S-3 filed by COMPASS details potential resale of up to 40m shares of $CMPS by various shareholders most notably atai. $ATAI could sell up to [--] million COMPASS shares. However this is also standard 'corporate housekeeping' as explained on recent earnings call"
[X Link](https://x.com/Psyched_Alpha/status/1701230760768778396) 2023-09-11T13:46Z 19.5K followers, [---] engagements
"Ann Arbor welcomes psychedelic plant festival for third year "The third annual Entheofest is a free-speech event focused on decriminalizing psychedelic plants and fungi across the state of Michigan.""
[X Link](https://x.com/Psyched_Alpha/status/1701233275883164039) 2023-09-11T13:56Z 19.5K followers, [---] engagements
"Tomorrow: Exploring the Ethical and Practical Considerations of Psychedelics Research The [----] OHRP Exploratory Workshop will be live-streamed tomorrow September 14th 9:45 AM 4:15 PM EDT"
[X Link](https://x.com/Psyched_Alpha/status/1701990974623244746) 2023-09-13T16:07Z 19.5K followers, [---] engagements
"Endpoints: MAPS plans to seek approval of MDMA-assisted therapy this year after second positive PhIII trial https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial/ https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial/"
[X Link](https://x.com/Psyched_Alpha/status/1702353379119235161) 2023-09-14T16:07Z 20K followers, [----] engagements
"Is the US Ready to Release the Therapeutic Potential of Psychedelics RBC Capital Markets speaks with MindMed CEO Rob Barrow https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic"
[X Link](https://x.com/Psyched_Alpha/status/1703004524577755448) 2023-09-16T11:14Z 19.9K followers, [---] engagements
"MDMA-Assisted Therapy Is One Step Closer to FDA Approval"
[X Link](https://x.com/Psyched_Alpha/status/1704443914688544825) 2023-09-20T10:34Z 19.2K followers, [----] engagements
"Bill aims to stop federal intervention in states allowing use of magic mushrooms A kind of Cole Memo for psychedelics: it would discourage federal law enforcement from intervening in states/localities that have reformed psychedelic drug policy"
[X Link](https://x.com/Psyched_Alpha/status/1704500671586648135) 2023-09-20T14:20Z 19.5K followers, [---] engagements
"California Senate Minority Leader Brian Jones Urges Governor Newsom to Veto Psychedelic Decrim. Bill (SB 58) "the idea of allowing the widespread uncontrolled and unsupervised use of these powerful drugs for self-medicating purposes is a scary prospect to many Californians""
[X Link](https://x.com/Psyched_Alpha/status/1704885116953059447) 2023-09-21T15:47Z 19.4K followers, [---] engagements
"Psychedelics Business Forum reMind Returns To Las Vegas "The event takes place at Westgate Las Vegas Resort & Casino on Nov. 28-29 as a popular pre-show forum show ahead of MJBizCon.""
[X Link](https://x.com/Psyched_Alpha/status/1705267793342452022) 2023-09-22T17:08Z 19.4K followers, [---] engagements
""Governor Newsom would be wise to sign this bill into law and other states and the federal government should follow suit.""
[X Link](https://x.com/Psyched_Alpha/status/1707433410732400736) 2023-09-28T16:33Z 19.4K followers, [---] engagements
"atai Life Sciences Announces Completion of Phase [--] Study of VLS-01in Healthy Participants atai's DMT candidate was "well-tolerated with a favorable safety profile". The company will test a "further optimized" version before initiating a Phase [--] study"
[X Link](https://x.com/Psyched_Alpha/status/1708943659180212601) 2023-10-02T20:34Z 19.2K followers, [---] engagements
"Unsealed Court Filing Reveals Email Exchange Between MindMed and Ceruvia Execs Stephen Hurst negotiated the exchange of GMP LSD with Carey Turnbull. In consideration the email contemplates a cash payment from $MNMD plus an agreement to not assert IP rights among other things"
[X Link](https://x.com/Psyched_Alpha/status/1710010890920042897) 2023-10-05T19:15Z 19.9K followers, [----] engagements
"Introducing the Psychedelic News Feed Every day we manually select news clippings research publications and commentary for inclusion: no aggregators or AI bots. Explore:"
[X Link](https://x.com/Psyched_Alpha/status/1711756340970864714) 2023-10-10T14:51Z 19.4K followers, [----] engagements
"This Senator Wants to Legalize Magic Mushrooms in Mexico @alelagunes says that psilocybin mushrooms could be a benefit to the country's mental health crisis"
[X Link](https://x.com/Psyched_Alpha/status/1712766134242427033) 2023-10-13T09:44Z 19.5K followers, [----] engagements
"Provides an overview of the company's IP which is claimed to be the "largest IP portfolio" in the psychedelic sector with [--] patents granted and over [---] pending"
[X Link](https://x.com/Psyched_Alpha/status/1719732818043916522) 2023-11-01T15:07Z 19.2K followers, [---] engagements
"Upcoming data: CYB003 Ph [--] topline efficacy data expected Q4 [----] CYB004 Ph [--] topline data in Q4 [----] Upcoming trials: [--] trials upcoming in 2024"
[X Link](https://x.com/Psyched_Alpha/status/1719733067126841681) 2023-11-01T15:08Z 19.2K followers, [---] engagements
"Now on to the CYB003 interim data which refers to cohorts [--] and 5"
[X Link](https://x.com/Psyched_Alpha/status/1719733958617800785) 2023-11-01T15:11Z 19.2K followers, [---] engagements
"Compass Pathways initiates UK component of global phase [--] study of psilocybin treatment in treatment-resistant depression and launches new research center "The COMP [---] trial will be conducted at research sites across the UK""
[X Link](https://x.com/Psyched_Alpha/status/1724754410545283484) 2023-11-15T11:41Z 19.2K followers, [---] engagements
"Psychedelic Patent Analysis This month: - MindMed scores psilocybin-antidepressant co-treatment patent - A spate of PCTs published from GH Research - Early fruits of Cybin's Small Pharma acquisition (Free P+ taster issue.) https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023"
[X Link](https://x.com/Psyched_Alpha/status/1728108925860364470) 2023-11-24T17:50Z 19.9K followers, [----] engagements
"Were at the reMind Psychedelics Business Forum in Las Vegas Discussions include psychedelic policy business harm reduction and beyond"
[X Link](https://x.com/Psyched_Alpha/status/1729593572154884479) 2023-11-28T20:10Z 19.2K followers, [---] engagements
"P+ Psychedelic Bulletin #151: Psilocybin for BDII ACNP Readouts Methylone for PTSD and More Psychedelic Drug Dev. News - Compass-Sponsored Study of Psilocybin in Bipolar Type II Finds Preliminary Safety and Efficacy - MindMed Shares Topline Results from LSD for Generalised Anxiety Disorder Study - Delix: First Look at DLX-001 Phase I Data - Intra-Cellular Therapies: Preclinical Data from Non-Hallucinogenic Psychedelics Program - Gilgamesh: Wraps Ph I Trial of GM-2505 - Cybin: Further CYB003 Data - Transcend: First Look at Ph [--] Methylone for PTSD Data and more."
[X Link](https://x.com/Psyched_Alpha/status/1735323128924922232) 2023-12-14T15:37Z 19.9K followers, [---] engagements
"Psychedelic Bulletin #152: Policy and Business Updates We review the DEA's latest psychedelic scheduling attempt psychedelics' inclusion in the NDAA Jamaica's Psilocybin Industry Working Group EMA's psychedelics Workshop in April [----] and much more"
[X Link](https://x.com/Psyched_Alpha/status/1738207871744024963) 2023-12-22T14:40Z 19.3K followers, [----] engagements
""Big Pharma Enters Psychedelics As AbbVie Buys Compass Pathways" is one of Cowen's 'Potential Surprises For 2024'. Cowen's top [--] potential surprises of [----] $XBI https://t.co/a3uziIlSrh Cowen's top [--] potential surprises of [----] $XBI https://t.co/a3uziIlSrh"
[X Link](https://x.com/Psyched_Alpha/status/1740997502399390006) 2023-12-30T07:25Z 19.4K followers, [----] engagements
"Q: Why didn't you buy the whole company A: Angermayer suggests Beckley wasn't open to full sale which he liked. Valuations in biotech are "distorted" and "super low" he said hinting part of motivation. Rao and Brand meanwhile keen to emphasise the data was the motivation"
[X Link](https://x.com/Psyched_Alpha/status/1742904123442274701) 2024-01-04T13:41Z 19.2K followers, [---] engagements
"BREAKING: MAPS PBC Closes $100m Series A Rebrands to Lykos Therapeutics We take a closer look at MAPS PBCs Series A rebrand to Lykos and what this might tell us about an organisation that so desperately wants to do things differently"
[X Link](https://x.com/Psyched_Alpha/status/1743256353131417698) 2024-01-05T13:01Z 19.4K followers, 19.1K engagements
"Magnesiumibogaine therapy in veterans with traumatic brain injuries A heavily-anticipated open-label study from Nolan Williams et al. was published today. ".resulted in significant improvements" in functioning PTSD depression and anxiety"
[X Link](https://x.com/Psyched_Alpha/status/1743274062107771273) 2024-01-05T14:11Z 19.5K followers, [----] engagements
"It's been a busy start to [----]. π€ atai scoops up 35.5% of Beckley Psytech via $50m investment π° MAPS PBC raises $100m Series A rebrands to Lykos Therapeutics π VA announces it will fund psychedelic research for first time since '60s .and more"
[X Link](https://x.com/Psyched_Alpha/status/1743364294316572815) 2024-01-05T20:10Z 19.5K followers, [---] engagements
"Psychedelics Are Going Mainstream. Investing in Them Hasnt. "Drugs like LSD have shown potential for treating psychiatric disorders. Wall Street and big pharma arent convinced.""
[X Link](https://x.com/Psyched_Alpha/status/1743658988980379905) 2024-01-06T15:41Z 19.2K followers, [---] engagements
"MindMed Scraps Sub-Perceptual LSD Program After ADHD Study Failed $MNMD will not develop its microdosing regimen of LSD any further as a PoC study of repeated sub-perceptual doses (20 g) in adults with ADHD failed to meet its primary endpoint. https://www.businesswire.com/news/home/20240108449557/en/MindMed-Announces-Business-Update-and-Anticipated-Milestones-for-2024 https://www.businesswire.com/news/home/20240108449557/en/MindMed-Announces-Business-Update-and-Anticipated-Milestones-for-2024"
[X Link](https://x.com/Psyched_Alpha/status/1744395663318581292) 2024-01-08T16:28Z 19.9K followers, [----] engagements
"SCOOP: The Obscure Advisory Panel Blocking Dozens of Psychedelic Studies in California Dozens of psychedelics are stuck in limbo despite being cleared by FDA DEA etc. costing $ millions and preventing new studies launching. Read our coverage:"
[X Link](https://x.com/Psyched_Alpha/status/1744730769317408859) 2024-01-09T14:40Z 19.4K followers, 10.2K engagements
"8. MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics Josh was invited to give a short presentation at the inaugural meeting of a psychedelics MEP Action Group at the European Parliament in Brussels"
[X Link](https://x.com/Psyched_Alpha/status/1745474912632861062) 2024-01-11T15:57Z 19.4K followers, [---] engagements
"9. P+: A Nue Lease of Life Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health We piece together the trajectory: from a buoyant Series A through a series of pivots and rumours of bankruptcy"
[X Link](https://x.com/anyuser/status/1745474915975733358) 2024-01-11T15:57Z [--] followers, [---] engagements
"10. MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD Our shortest popular story of the year was the breaking news that MAPS PBC (now Lykos) had filed a New Drug Application (NDA) for MDMA-Assisted Therapy for PTSD with the FDA"
[X Link](https://x.com/Psyched_Alpha/status/1745474918936957310) 2024-01-11T15:57Z 19.4K followers, [---] engagements
"Psychedelic Bulletin #153 MindMed Scraps LSD Microdosing Ibogaine in TBI Study Compass' Research Collab. with Greenbrook Preclinical Results: Gilgameshs GM-1020 Cybin Shares Topline dDMT Data atai's EMP-01 Ph I Readout and more. https://psychedelicalpha.com/news/psychedelic-bulletin-153-mindmed-scraps-microdosing-program-eagerly-anticipated-ibogaine-study-publishes-compass-collaborates-with-greenbrook-gilgameshs-gm-1020-readout-and-more"
[X Link](https://x.com/Psyched_Alpha/status/1745803244071166243) 2024-01-12T13:41Z 19.9K followers, [----] engagements
"Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health The news comes just two weeks afterCompass announced a research collaboration withGreenbrook TMS. https://www.globenewswire.com/news-release/2024/01/16/2809793/0/en/Compass-Pathways-enters-into-research-collaboration-agreement-with-Hackensack-Meridian-Health-to-develop-optimal-clinical-model-for-investigational-COMP360-psilocybin-treatment-if-.html"
[X Link](https://x.com/Psyched_Alpha/status/1747247720274739424) 2024-01-16T13:21Z 19.9K followers, [---] engagements
"When ordered by marketcap we see that $CMPS $ATAI and $GHRS are the largest public psychedelics companies. This was true for [----] too"
[X Link](https://x.com/Psyched_Alpha/status/1748023288045936864) 2024-01-18T16:43Z 19.4K followers, [---] engagements
"Our report also includes case studies of individual psychedelics stocks. Cybin's for example appreciated significantly following its announcement of the Small Pharma acquisition"
[X Link](https://x.com/Psyched_Alpha/status/1748023291581792282) 2024-01-18T16:43Z 19.4K followers, [---] engagements
""We support the decriminalization of psychedelic use and the protection of Indigenous practices but we believe that policies such as Oregons outpace evidence on psilocybins safety" - Paul Appelbaum William Smith and Dominic Sisti"
[X Link](https://x.com/Psyched_Alpha/status/1748031760489763124) 2024-01-18T17:17Z 19.4K followers, [---] engagements
"Psychedelics M&A and Partnerships in [----] We review 2023's mergers acquisitions and partnerships in the psychedelics industry including Otsuka's purchase of Mindset Pharma and Cybin's acquisition of Small Pharma. https://psychedelicalpha.com/news/psychedelics-ma-and-partnerships-in-2023 https://psychedelicalpha.com/news/psychedelics-ma-and-partnerships-in-2023"
[X Link](https://x.com/Psyched_Alpha/status/1749443929399775737) 2024-01-22T14:48Z 20K followers, [---] engagements
""expectancy for escitalopram was associated with improved therapeutic outcomes to escitalopram but expectancy for psilocybin was not predictive of response to psilocybin""
[X Link](https://x.com/Psyched_Alpha/status/1749774411027107970) 2024-01-23T12:41Z 19.4K followers, [----] engagements
"Investors pile into psychedelic drug start-ups tackling mental health "Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing mind-altering substances""
[X Link](https://x.com/Psyched_Alpha/status/1756304232779571503) 2024-02-10T13:08Z 19.5K followers, [----] engagements
"One of the at-home ketamine industry's biggest boosters has turned bearish. Juan Pablo Cappello who raised (and spent) tens of millions as CEO of Nue Life Health is now concerned that the profit motive can lead to poor patient outcomes"
[X Link](https://x.com/Psyched_Alpha/status/1764692825743003737) 2024-03-04T16:42Z 19.6K followers, [----] engagements
"FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase [--] Program Plans Our coverage: https://psychedelicalpha.com/news/fda-hands-mindmeds-lsd-candidate-breakthrough-therapy-designation-in-generalised-anxiety-disorder-company-provides-12-week-data-and-fleshes-out-phase-3-program-plans https://psychedelicalpha.com/news/fda-hands-mindmeds-lsd-candidate-breakthrough-therapy-designation-in-generalised-anxiety-disorder-company-provides-12-week-data-and-fleshes-out-phase-3-program-plans"
[X Link](https://x.com/Psyched_Alpha/status/1765780606309536098) 2024-03-07T16:44Z 19.9K followers, [----] engagements
"P+ Psychedelic Bulletin #159 Patient Access re: MDMA-Assisted Therapy Doblin on the Future of Psychedelics Whole Mushroom vs. Synthetic Psilocybin Usona Launches Phase [--] Study BTDs Attract Investors for MindMed and Cybin And more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-159-patient-access-to-mdma-assisted-therapy-notes-from-sxsw-whole-mushroom-vs-synthetic-psilocybin https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-159-patient-access-to-mdma-assisted-therapy-notes-from-sxsw-whole-mushroom-vs-synthetic-psilocybin"
[X Link](https://x.com/Psyched_Alpha/status/1770867885361037774) 2024-03-21T17:39Z 19.9K followers, [----] engagements
"MindMeds Total Elimination of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies We look at MindMed's claim to have eliminated psychotherapy from its Phase 2b study and explore the broader Spravato-isation of PATs. https://psychedelicalpha.com/news/mindmeds-total-elimination-of-psychotherapy-in-lsd-study-stokes-debate-around-its-role-in-psychedelic-therapies https://psychedelicalpha.com/news/mindmeds-total-elimination-of-psychotherapy-in-lsd-study-stokes-debate-around-its-role-in-psychedelic-therapies"
[X Link](https://x.com/Psyched_Alpha/status/1776312979341844539) 2024-04-05T18:16Z 19.9K followers, [----] engagements
"Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase [--] Studies of 4-HO-DiPT Prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug"
[X Link](https://x.com/Psyched_Alpha/status/1786400618074005846) 2024-05-03T14:21Z 19.7K followers, [---] engagements
"Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals AbbVie has become the latest large pharmaceutical company to dip its toes into psychedelic drug development as it announced what might be the most substantial foray of its kind this morning. https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals"
[X Link](https://x.com/Psyched_Alpha/status/1790016964724723871) 2024-05-13T13:51Z 19.8K followers, [----] engagements
"Temporary Memorial at the Capitol Calls on FDA to Follow the Science and Approve Lykos MDMA A memorial in DC consists of [------] dog tags and bears the message APPROVE MDMA-ASSISTED THERAPY FOR PTSD. Photo: Grunt Style Foundation via LinkedIn"
[X Link](https://x.com/Psyched_Alpha/status/1811133293968105596) 2024-07-10T20:20Z 19.9K followers, 17.1K engagements
"Google co-founder backs Ibogaine biotech studying psychedelic African shrub Sergey Brins non-profit funds research into using hallucinogen for mental health treatment https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68"
[X Link](https://x.com/Psyched_Alpha/status/1815031042618614156) 2024-07-21T14:28Z 19.9K followers, [----] engagements
"J&J Files Supplemental NDA with FDA Seeking Approval of Spravato as Monotherapy for Treatment-Resistant Depression If approved the esketamine nasal spray would become the first monotherapy for adults with TRD. https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-u-s-fda-approval-of-spravato-esketamine-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-u-s-fda-approval-of-spravato-esketamine-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression"
[X Link](https://x.com/Psyched_Alpha/status/1815705965695479935) 2024-07-23T11:10Z 19.9K followers, [---] engagements
"MindMed Announces $75M Public Offering Expected to close Monday. Cash will be used "to fund the research and development of its product candidates and working capital and general corporate purposes." https://www.businesswire.com/news/home/20240809560954/en/ https://www.businesswire.com/news/home/20240809560954/en/"
[X Link](https://x.com/Psyched_Alpha/status/1821928451797881130) 2024-08-09T15:16Z 19.9K followers, [----] engagements
"P+ Psychedelic Bulletin #170 - MindMed Tops Up Healthy Cash Balance with $75M Raise; Eyes Adding Depression to Pipeline - atai Approaches Ph [--] for DMT and R-MDMA Candidates - Compass Ph [--] Generally On-Track Potential for Slight Delay - & more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-170-is-mindmed-eyeing-depression-atai-approaches-phase-2-for-dmt-and-r-mdma-candidates-compass-phase-3-readout-timeline-european-psychiatrists-remain-open-to-psych"
[X Link](https://x.com/Psyched_Alpha/status/1824056977485410379) 2024-08-15T12:14Z 19.9K followers, [----] engagements
"What Does FDA Expect from Lykos Next Phase [--] MDMA Study (Part 2) Here we look at: - Accounting for Euphoria and Other Positive Adverse Events - Phasing Out Private Practices - Addressing Selection Bias - Give the Reins to a CRO https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-2 https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-2"
[X Link](https://x.com/Psyched_Alpha/status/1828792677158265256) 2024-08-28T13:52Z 20K followers, [---] engagements
"New Job Opportunity: Generalist (BD/Ops) at a Psychedelics Biotech Company More info. https://jobs.psychedelicalpha.com/generalist-business-development-operations-358b35816f95 https://jobs.psychedelicalpha.com/generalist-business-development-operations-358b35816f95"
[X Link](https://x.com/Psyched_Alpha/status/1831416484612264159) 2024-09-04T19:38Z 20K followers, [---] engagements
"Psychedelics for mental health among the 'biggest wellness trends of 2024' according to The Guardian. https://www.theguardian.com/wellness/article/2024/sep/04/2024-wellness-trends https://www.theguardian.com/wellness/article/2024/sep/04/2024-wellness-trends"
[X Link](https://x.com/Psyched_Alpha/status/1831419167817535979) 2024-09-04T19:48Z 20K followers, [---] engagements
"Cochrane Review finds that certainty of evidence is "low to very low" for psychedelic-assisted therapy in the treatment of anxiety depression and existential distress in people with life-threatening diseases. More: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015383.pub2/full https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015383.pub2/full"
[X Link](https://x.com/Psyched_Alpha/status/1834180833210487097) 2024-09-12T10:42Z 20K followers, 10.5K engagements
"Breaking: Psyence Biomed Backs Out of Clairvoyant Therapeutics Acquisition Less than a month after announcing it would acquire psilocybin drug developer Clairvoyant Psyence ($PBM) says it has walked away. https://www.globenewswire.com/news-release/2024/10/04/2958503/0/en/Psyence-Biomed-Provides-Update-on-Previously-Announced-Acquisition-of-Clairvoyant.html https://www.globenewswire.com/news-release/2024/10/04/2958503/0/en/Psyence-Biomed-Provides-Update-on-Previously-Announced-Acquisition-of-Clairvoyant.html"
[X Link](https://x.com/Psyched_Alpha/status/1842301030446588114) 2024-10-04T20:29Z 20K followers, [----] engagements
"Natural Medicine Advisory Bulletin [--] Vicente LLP looks at big-picture questions as the program hurtles towards launch. First up are fees and rule changes before the firm reviews Natural Medicine-related meetings since our last Bulletin in late Aug. https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-14 https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-14"
[X Link](https://x.com/Psyched_Alpha/status/1849483475348299935) 2024-10-24T16:09Z 20.5K followers, [---] engagements
"Sen. Kyrsten Sinema on MDMA-AT: It makes sense for Congress to keep it in the VA and DOD world and partner with the private community that is making leaps and bounds https://www.fiercehealthcare.com/health-tech/hlth-2024-recap-5-notable-trends-spotted-reporters-and-takeaways-executives#::text=Psychedelic%20medicine%20session%20draws%20a%20crowd https://www.fiercehealthcare.com/health-tech/hlth-2024-recap-5-notable-trends-spotted-reporters-and-takeaways-executives#::text=Psychedelic%20medicine%20session%20draws%20a%20crowd"
[X Link](https://x.com/Psyched_Alpha/status/1850939770836586704) 2024-10-28T16:36Z 20.5K followers, [----] engagements
""The FDA has never approved a drug before that requires certain type or length of therapy which MDMA would so this is uncharted territory". Sinema was speaking at HLTH 2024"
[X Link](https://x.com/Psyched_Alpha/status/1850939772862419391) 2024-10-28T16:36Z 20.5K followers, [---] engagements
"New Association Launches to Expand Patient Access to Psychedelic Medicines Founding members include Compass B. More Lykos Therapeutics and MindMed. The group's Scientific Advisors include Peter Hendricks Paul Huston Sandeep Nayak and Jennifer Jones. https://www.psychedelicsrx.org/new-association-launches-to-expand-patient-access-to-psychedelic-medicines/ https://www.psychedelicsrx.org/new-association-launches-to-expand-patient-access-to-psychedelic-medicines/"
[X Link](https://x.com/Psyched_Alpha/status/1859190617185599921) 2024-11-20T11:02Z 19.9K followers, [---] engagements
"P+ Psychedelic Bulletin [---] - Last-Minute Rule Changes Opt-Outs Ahead of Colorados Psychedelics Program Launch - Cybins $CYBN Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-181 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-181"
[X Link](https://x.com/Psyched_Alpha/status/1860004015171600630) 2024-11-22T16:54Z 20K followers, [----] engagements
"MindMed $MNMD CEO Robert Barrow tells Endpoints that the incoming Trump administration could potentially help slash some of the bureaucracy that hampers the development of psychedelic drugs. What were seeing is a broad willingness to engage and support efficiency he said"
[X Link](https://x.com/Psyched_Alpha/status/1860030641917820946) 2024-11-22T18:40Z 19.9K followers, [----] engagements
"What are Psychedelics Investors Excited About We take a close look at what psychedelics investors are most excited about using quantitative and qualitative data from our Q3'24 psychedelic investor survey. https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-excited-about https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-excited-about"
[X Link](https://x.com/Psyched_Alpha/status/1861047387487179208) 2024-11-25T14:00Z 20K followers, [---] engagements
"P+ Psychedelic Bulletin #182: - Psychedelics Insiders Trump [---] Wishlist - Doblin Reflects on Lykos Strategy - Polish Psilocybin Study Scores $4M in Funding - Alleged Killer of UnitedHealth CEO Apparently Interested in Psychedelics More. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-182-psychedelics-insiders-trump-2-0-wishlist-doblin-reflects-on-lykos-strategy-polish-psilocybin-study-scores-4m-in-funding"
[X Link](https://x.com/Psyched_Alpha/status/1866497011219939549) 2024-12-10T14:55Z 20K followers, [---] engagements
"- Reflecting on UW Madisons 4th Annual Psychedelic Symposium - MindMed Doses First Patient in Phase [--] LSD Program - Beckley Psytech Shares Small Cut of Data from Phase 2a Study of IV Psilocin in MDD - Psilocybin for COVID Clinicians - & more https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-183 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-183"
[X Link](https://x.com/Psyched_Alpha/status/1869442716092055611) 2024-12-18T18:00Z 19.9K followers, [---] engagements
"SCOOP: PSFCs $130M Roadmap to Shape the Future of Psychedelic Philanthropy https://psychedelicalpha.com/news/scoop-psfcs-130m-roadmap-to-shape-the-future-of-psychedelic-philanthropy https://psychedelicalpha.com/news/scoop-psfcs-130m-roadmap-to-shape-the-future-of-psychedelic-philanthropy"
[X Link](https://x.com/Psyched_Alpha/status/1870111594513863107) 2024-12-20T14:18Z 20K followers, [----] engagements
"Colorado's Department of Regulatory Agencies makes eleventh-hour changes to regulated psychedelics program rules to restrict at-home administration. Viability of microdosing via the program remains up in the air. https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-15-a-duplicitous-december https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-15-a-duplicitous-december"
[X Link](https://x.com/Psyched_Alpha/status/1876076258846749018) 2025-01-06T01:20Z 20K followers, [----] engagements
"Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblins Backing Now the companys board must decide whether to stick with its current lead investor Helena or accept Gracias proposal. https://psychedelicalpha.com/news/billionaire-investor-antonio-gracias-plots-100m-lykos-takeover-with-doblins-backing https://psychedelicalpha.com/news/billionaire-investor-antonio-gracias-plots-100m-lykos-takeover-with-doblins-backing"
[X Link](https://x.com/Psyched_Alpha/status/1877719092590977402) 2025-01-10T14:08Z 19.9K followers, [----] engagements
"The PsychedeliCare Initiative launches effort to gather 1M+ signatures in support of the European Commission taking meaningful action re: funding psychedelic research standardising psychedelic therapy approaches and rescheduling psychedelics. https://psychedelicalpha.com/news/psychedelicare-launches-first-european-citizens-initiative-demanding-political-action-on-psychedelic-assisted-therapies https://psychedelicalpha.com/news/psychedelicare-launches-first-european-citizens-initiative-demanding-political-action-on-psychedelic-assisted-therapies"
[X Link](https://x.com/Psyched_Alpha/status/1879120664059347143) 2025-01-14T10:57Z 19.9K followers, [---] engagements
"2025 Florida Farm Bill Closes 'Loophole' for Sale of Psychedelic Mushrooms Press release says the bill includes: "Eliminating the loophole for the sale of psychedelic mushrooms.""
[X Link](https://x.com/Psyched_Alpha/status/1886858619875967449) 2025-02-04T19:25Z 19.9K followers, [----] engagements
"The psychedelics field has lost a champion at the VA as Shereef Elnahal vacates his post as Under Secretary for Veterans Health. He has since revealed that he has taken a position as Executive Health Advisor to VC firm Thrive Capital. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-188-q424-lobbying-update-virginia-lawmakers-question-purpose-precedent-of-compass-bill-va-loses-psychedelics-champion-gh-discusses-lack-of-placebo-effect"
[X Link](https://x.com/Psyched_Alpha/status/1890513094486683656) 2025-02-14T21:27Z 20.1K followers, [---] engagements
"LSD Microdosing Not Effective for ADHD The results from the first randomised trial of microdosing LSD for ADHD are in: "LSD was not efficacious in reducing ADHD symptoms compared with placebo""
[X Link](https://x.com/Psyched_Alpha/status/1902565267756220449) 2025-03-20T03:38Z 19.9K followers, [----] engagements
"Christian Angermayers psychedelic drug developer $ATAI has announced that it is adding $5M worth of Bitcoin to its treasury. In an article published on LinkedIn Angermayer wrote about What Psychedelics and Bitcoin have in common. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-192-psychedelic-safety-compass-lacklustre-long-term-data-lsd-microdosing-no-better-than-placebo-in-adhd https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-192-psychedelic-safety-compass-lacklustre-long-term-data-lsd-microdosing-no-better-than-placebo-in-adhd"
[X Link](https://x.com/Psyched_Alpha/status/1905631671707115926) 2025-03-28T14:42Z 20.1K followers, [---] engagements
"Psychedelic Alpha Launches TripRadar We are very pleased to launch our latest product: TripRadar which allows you to see share and sync with the global psychedelic experience in real time. Our new app has several unique features"
[X Link](https://x.com/Psyched_Alpha/status/1907085737318625444) 2025-04-01T15:00Z 20.5K followers, [----] engagements
"Will MDMA be FDA-approved by the end of [----] Yes No Yes No"
[X Link](https://x.com/Psyched_Alpha/status/1909727563406098514) 2025-04-08T21:58Z 20.1K followers, [---] engagements
"In late June $CMPS will readout the first of two Ph [--] studies of psilocybin for treatment-resistant depression. It's seen by many as make-or-break for the company and will have ramifications for the broader field of psychedelic drug devs. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-194-make-or-break-moment-looms-for-compass-rfk-jr-discusses-lsd-use-europes-next-chapter-in-psychedelic-therapy-begins-in-barcelona"
[X Link](https://x.com/Psyched_Alpha/status/1916528768275161594) 2025-04-27T16:24Z 20.2K followers, [---] engagements
"Otsuka Eyes Psychedelic Future in Japan with New Infrastructure Drive Otsuka has announced a joint research agreement to build infrastructure for the social implementation of psychedelics in Japan long defined by strict drug laws & deep stigma. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans"
[X Link](https://x.com/Psyched_Alpha/status/1920859333081919563) 2025-05-09T15:12Z 20K followers, [----] engagements
"Psychedelic Alpha Readers Cautiously Optimistic Re: Compass Pathways' ( $CMPS ) Upcoming Phase [--] Readout Last week we asked what sort of results you're expecting from Compass Phase [--] psilocybin for treatment-resistant depression study readout expected in late June"
[X Link](https://x.com/Psyched_Alpha/status/1921572743926964699) 2025-05-11T14:26Z 20.2K followers, [----] engagements
"Half of ASCP 2025's Pharmaceutical Pipeline Features Psychedelics In our latest Bulletin we review the dozens of poster and presentation abstracts to bring you a preview. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans"
[X Link](https://x.com/Psyched_Alpha/status/1921946969980997942) 2025-05-12T15:14Z 20K followers, [----] engagements
"Psychedelics in Japan: A Conversation with Dr. Hiroyuki Uchida Our first bilingual interview features a conversation with the man at the forefront of psychedelic research in Japan: @Uchida_Keio_Psy. https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead"
[X Link](https://x.com/Psyched_Alpha/status/1925194524915113987) 2025-05-21T14:18Z 20K followers, [----] engagements
"Carolina Seybert psychologist and researcher at Champalimaud Foundation reflects on an event last Monday that saw the leaders of a half-dozen Portuguese health-related professional bodies launch their recommendations on the clinical use of psychedelics. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-197-portugese-health-related-professions-unite-on-psychedelics-shrooms-shots-and-the-next-surgeon-general-religious-leaders-study-set-to-publish"
[X Link](https://x.com/Psyched_Alpha/status/1925207202421415939) 2025-05-21T15:09Z 20K followers, [---] engagements
"In a recent interview with Psychedelic Alpha researcher @Uchida_Keio_Psy explained how various elements of psychedelic research and roll-out must be attuned to the Japanese context. Read more in the full interview available in both English & Japanese: https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead"
[X Link](https://x.com/Psyched_Alpha/status/1925271375419506836) 2025-05-21T19:24Z 20K followers, [---] engagements
"BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria. https://psychedelicalpha.com/news/breaking-atai-moves-to-acquire-beckley-if-phase-2b-5-meo-dmt-data-delivers https://psychedelicalpha.com/news/breaking-atai-moves-to-acquire-beckley-if-phase-2b-5-meo-dmt-data-delivers"
[X Link](https://x.com/Psyched_Alpha/status/1929480682788495598) 2025-06-02T10:10Z 20.2K followers, 14.1K engagements
"After a sluggish start $ATAI stock is up 11.5% today. On the monthly it's up 72%. BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria. https://t.co/6jOb1U9SEy BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria."
[X Link](https://x.com/Psyched_Alpha/status/1929583621574132115) 2025-06-02T16:59Z 20.3K followers, [----] engagements
"Speaking at Prague Castle @RickDoblin of @MAPS presents on the potential of psychedelic therapies for war veterans. As part of his presentation he shared our Psychedelic Drug Development Bullseye Chart among other resources"
[X Link](https://x.com/Psyched_Alpha/status/1932034551326367947) 2025-06-09T11:18Z 20.1K followers, [---] engagements
"Can Czechia Deliver on Psilocybin Access and Provide a Model for the Continent In Bulletin [---] we took a deep dive into that question. Read the full analysis for free: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-200-can-czechia-deliver-on-psilocybin-access-a-closer-look-at-atai-beckley-q125-psychedelic-lobbying-update-catching-up-with-the-class-of-bulletin-100 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-200-can-czechia-deliver-on-psilocybin-access-a-closer-look-at-atai-beckley-q125-psychedelic-lobbying-update-catching-up-with-the-class-of-bulletin-100"
[X Link](https://x.com/Psyched_Alpha/status/1932504536389693533) 2025-06-10T18:26Z 20.1K followers, [---] engagements
"Texas Governor Greg Abbott has signed SB [----] the Texas Ibogaine Initiative into law. Read more in Bulletin 201: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-201-dispatches-from-prague-and-london-texas-becomes-leader-in-ibogaine-research-as-governor-signs-50m-match-funding-bill-high-dose-lsd-shows-potential-in-depression-but-fi https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-201-dispatches-from-prague-and-london-texas-becomes-leader-in-ibogaine-research-as-governor-signs-50m-match-funding-bill-high-dose-lsd-shows-potential-in-depression-but-fi"
[X Link](https://x.com/Psyched_Alpha/status/1933547012600799311) 2025-06-13T15:28Z 20.1K followers, [----] engagements
"Australias largest health insurance company Medibank has carved out AUD $10M (USD $6.5M) to fund a psychedelic therapy pilot program for its eligible members who wont pay a penny in out-of-pocket costs. More: https://psychedelicalpha.com/news/australias-largest-private-health-insurer-commits-10m-to-fund-mdma-therapy-for-ptsd-in-first-of-its-kind-program https://psychedelicalpha.com/news/australias-largest-private-health-insurer-commits-10m-to-fund-mdma-therapy-for-ptsd-in-first-of-its-kind-program"
[X Link](https://x.com/Psyched_Alpha/status/1935133081997877259) 2025-06-18T00:30Z 20.2K followers, [----] engagements
"Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://psychedelicalpha.com/news/compass-pathways-psilocybin-clears-first-phase-3-hurdle https://psychedelicalpha.com/news/compass-pathways-psilocybin-clears-first-phase-3-hurdle"
[X Link](https://x.com/Psyched_Alpha/status/1937096734657659037) 2025-06-23T10:33Z 20.5K followers, 31.5K engagements
"$CMPS opens 33% down with marketcap shaved to $300M at the time of writing. Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://t.co/wF6AOPneSu https://t.co/ee7f0zAngc Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://t.co/wF6AOPneSu https://t.co/ee7f0zAngc"
[X Link](https://x.com/Psyched_Alpha/status/1937141405777801617) 2025-06-23T13:31Z 20.5K followers, [----] engagements
"Cautious Optimism Lingering Questions: Researchers React to Compass Phase [--] Psilocybin Results We spoke with @Uchida_Keio_Psy @AicherHelena @TheBorisLab @trpwolff @thebandlab and others for our researchers react piece. https://psychedelicalpha.com/news/cautious-optimism-lingering-questions-researchers-react-to-compass-phase-3-psilocybin-results https://psychedelicalpha.com/news/cautious-optimism-lingering-questions-researchers-react-to-compass-phase-3-psilocybin-results"
[X Link](https://x.com/Psyched_Alpha/status/1937894097794056358) 2025-06-25T15:22Z 20.2K followers, [----] engagements
"P+ Psychedelic Bulletin #202: - Psychedelics Access Within [--] Months RFK Jr. Says; Psychedelics in Washington - Lykos New CEO CMO - New Zealands First Psilocybin Prescriber - Judge Recommends Schedule I Placement for DOI and DOC - and more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-202-psychedelics-access-within-12-months-rfk-jr-says-psychedelics-in-washington-lykos-new-ceo-cmo-new-zealands-first-psilocybi"
[X Link](https://x.com/Psyched_Alpha/status/1938677665654866062) 2025-06-27T19:15Z 20.3K followers, [---] engagements
"Last week New Zealands Deputy Prime Minister David Seymour announced that one highly experienced psychiatrist has been granted permission to prescribe psilocybin to patients with treatment-resistant depression. That psychiatrist is Dr Cameron Lacey who led the first trial of psilocybin in the country. The Deputy PM described the move as huge for people with depression whove tried everything else and are still suffering. Read more in Bulletin 202:"
[X Link](https://x.com/Psyched_Alpha/status/1939352409517744218) 2025-06-29T15:57Z 20.3K followers, [---] engagements
"In a decision issued on June 20th World Psychedelics Day a Drug Enforcement Administration (DEA) Administrative Law Judge recommended the placement of DOI and DOC in Schedule I. The lawyers behind the challenge to that action were Robert Rush and Brett Phelps. The pair say that they are prepared to fight these terrible attacks on psychedelic science. Read more in Bulletin 202: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-202-psychedelics-access-within-12-months-rfk-jr-says-psychedelics-in-washington-lykos-new-ceo-cmo-new-zealands-first-psiloc"
[X Link](https://x.com/Psyched_Alpha/status/1940758676274647047) 2025-07-03T13:05Z 20.2K followers, [---] engagements
"Prof Andrew McIntosh is hoping to establish a ketamine clinic at the Royal Edinburgh Hospital for patients with treatment-resistant depression. A small number of private clinics offer ketamine for depression in the UK and the Oxford Health NHS Foundation Trust offers it too. But all of those options are self-pay which is something of a foreign concept to many Brits who rely on the National Health Service to provide healthcare that is free at the point of access. McIntosh is hoping to secure funding from the Scottish government. Read more in Bulletin 202:"
[X Link](https://x.com/Psyched_Alpha/status/1941136414877581391) 2025-07-04T14:06Z 20.3K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Psyched_Alpha Psychedelic AlphaPsychedelic Alpha posts on X about $nlb, $mmed, $numi, $mnmd the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.
Social category influence finance stocks countries exchanges travel destinations celebrities technology brands cryptocurrencies social networks currencies
Social topic influence $nlb, $mmed, $numi, $mnmd, health, $cmps, $enbi, $cybn, $atai, alpha
Top accounts mentioned or mentioned by @uchidakeiopsy @joshhardman @calyxlaw @healingadvfunds @greenstarbio @eleusianbio @psychedelicunit @alelagunes @rickdoblin @maps @aicherhelena @theborislab @trpwolff @thebandlab @doctorchrisvt @xandvt @flobrand @rosmcalpine @eddietalksdrugs @henrikjung
Top assets mentioned COMPASS Pathways plc (CMPS) Atai Life Sciences B.V. (ATAI) Alpha Technology Group Limited (ATGL) AbbVie Inc (ABBV) GH Research PLC (GHRS) TripAdvisor, Inc. (TRIP) BuzzCoin (BUZZ) DMarket (DMT)
Top posts by engagements in the last [--] hours
"Will $LKYSD be the US OTC ticker for $NUMI Just over an hour ago hints appeared on the OTC Markets register. More here. https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd"
X Link 2020-05-20T09:17Z 20.3K followers, [--] engagements
"$NUMI US OTC ticker $LKYSD appears to be available for pre-market orders on E-Trade"
X Link 2020-05-20T09:50Z 20.3K followers, [--] engagements
"Numinus listing day: $NUMI appearing on brokerages some accepting pre-market orders: Will $LKYSD be the US OTC ticker More here: https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numi-begins-appearing-on-brokerages-available-for-pre-market-orders-on-some https://psilocybinalpha.com/news/numinus-us-otc-ticker-lkysd https://psilocybinalpha.com/news/numi-begins-appearing-on-brokerages-available-for-pre-market-orders-on-some"
X Link 2020-05-20T11:25Z 20.3K followers, [--] engagements
"Did the ticker $LKYSF disappear on your brokerage's app or site It has most likely changed to $LKYSD $NUMI"
X Link 2020-05-20T12:18Z 20.3K followers, [--] engagements
"We have updated our guide on where you can buy psychedelic stocks in the US and internationally. $NUMI $MMED $SHRM $RVV $HOLL"
X Link 2020-05-21T20:04Z 20.4K followers, [--] engagements
"Looking to get an overview of the psychedelic stock market Our watchlist displays prices volumes market caps and 5-day changes for the top stocks. Including: $SHRM $MMED $NUMI $HOLL $RVV $BOSS $NLB https://psilocybinalpha.com/psychedelic-stock-watchlist https://psilocybinalpha.com/psychedelic-stock-watchlist"
X Link 2020-05-21T22:45Z 20.4K followers, [--] engagements
"FYI: TD Ameritrade appears to be experiencing issues. $LKYSD $MMEDF $SHRMF $RVVTF $HSTRF etc"
X Link 2020-05-22T13:46Z 20.3K followers, [--] engagements
"NewLeaf Brands'announves that their private placement at $0.30 a share with a hold period of [--] months has oversubscribed demand. $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-brands-announces-oversubscription-of-brokered-private-placement-led-by-canaccord-genuity https://psilocybinalpha.com/news/newleaf-brands-announces-oversubscription-of-brokered-private-placement-led-by-canaccord-genuity"
X Link 2020-05-22T20:46Z 20.3K followers, [--] engagements
"We spoke to Dr. Evan Wood Chief Medical Officer of Numinus $NUMI $LKYSD https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus"
X Link 2020-05-23T00:05Z 20.3K followers, [--] engagements
"When we spoke to Dr. Evan Wood CMO of Numinus he told us that he expects his incoming team to share the values of putting the public interest first. This is similar to what we have seen in interviews with Numinus' Founder Payton Nyquvest. $NUMI $LKYSD https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus https://psilocybinalpha.com/news/interview-with-dr-evan-wood-cmo-at-numinus"
X Link 2020-05-23T11:05Z 20.3K followers, [--] engagements
"Our Psychedelic Stock Watchlist provides a quick-glance overview at the state of the market. Stocks include: $MMED $NUMI $SHRM $RVV $NLB $HOLL $WUHN $MOTA and more. https://psilocybinalpha.com/psychedelic-stock-watchlist https://psilocybinalpha.com/psychedelic-stock-watchlist"
X Link 2020-05-24T13:01Z 20.4K followers, [--] engagements
"Free Event co-hosted by the Canadian Securities Exchange: Investing in Psychedelics Participants include: Field Trip MindLeap BrightMinds Champignon $SHRM Revive $RVV Hollister $HOLL and more. Register here: https://www.eventbrite.ca/e/investing-in-psychedelics-tickets-105591250272utm_campaign=new_attendee&utm_medium=email&utm_source=eb_email&utm_term=event_name https://www.eventbrite.ca/e/investing-in-psychedelics-tickets-105591250272utm_campaign=new_attendee&utm_medium=email&utm_source=eb_email&utm_term=event_name"
X Link 2020-05-24T14:31Z 20.4K followers, [--] engagements
"NewLeaf Brands' latest Advisor has "extensive knowledge for treating people with homeopathic medicine." Does this bring confusion to the psychedelic medicine space conflating substances like psilocybin with homeopathy $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-announces-advisor-appointee-dr-aubrey-oliver-to-spearhead-jamaican-based-psilocybin-retreat-efforts https://psilocybinalpha.com/news/newleaf-announces-advisor-appointee-dr-aubrey-oliver-to-spearhead-jamaican-based-psilocybin-retreat-efforts"
X Link 2020-05-26T13:03Z 20.3K followers, [--] engagements
"NewLeaf Brands provides recap of Company developments. $NLB $NLBIF https://psilocybinalpha.com/news/newleaf-brands-provides-an-update-to-its-shareholders-on-recent-corporate-developments-and-shares-a-positive-outlook https://psilocybinalpha.com/news/newleaf-brands-provides-an-update-to-its-shareholders-on-recent-corporate-developments-and-shares-a-positive-outlook"
X Link 2020-05-28T09:12Z 20.3K followers, [--] engagements
"NewLeaf Brands Name Change: NewLeaf Brands Inc. β‘ Mydecine Innovations Group Inc. NLB β‘ MYCO $NLB $NLBIF $MYCO https://psilocybinalpha.com/news/newleaf-brands-announces-name-and-stock-ticker-symbol-change-to-mydecine-innovations-group-inc-cse-myco https://psilocybinalpha.com/news/newleaf-brands-announces-name-and-stock-ticker-symbol-change-to-mydecine-innovations-group-inc-cse-myco"
X Link 2020-06-01T11:39Z 20.3K followers, [--] engagements
"NewLeaf (soon to be Mydecine) announces move into [----] sqft mycology R&D lab in Denver Colorado. $NLB $NLBIF $MYCO https://psilocybinalpha.com/news/newleaf-brands-announces-its-move-into-state-of-the-art-7500-sq-ft-specialty-mycology-rd-and-product-development-lab-in-denver-colorado https://psilocybinalpha.com/news/newleaf-brands-announces-its-move-into-state-of-the-art-7500-sq-ft-specialty-mycology-rd-and-product-development-lab-in-denver-colorado"
X Link 2020-06-02T11:28Z 20.3K followers, [--] engagements
"New Public Company Enters the Psychedelic Sector GreenStar Biosciences ( $GSTR ) is to acquire Toronto-based Eleusian Biosciences which has filed a provisional patent application in the US for psilocybin and N-Acetylcysteine combination therapy. https://psilocybinalpha.com/news/greenstar-biosciences-signs-agreement-to-acquire-100-of-eleusian-biosciences-corp https://psilocybinalpha.com/news/greenstar-biosciences-signs-agreement-to-acquire-100-of-eleusian-biosciences-corp"
X Link 2020-06-16T17:53Z 20.6K followers, [--] engagements
"We strive to keep our directory of psychedelic stocks updated. We just added GreenStar Biosciences ( $GSTR ) following the announcement that they are to acquire Eleusian Biosciences. Full resource here: https://psilocybinalpha.com/psilocybin-stocks-shroom-stocks https://psilocybinalpha.com/psilocybin-stocks-shroom-stocks"
X Link 2020-06-16T18:03Z 20.5K followers, [--] engagements
"We spoke to @GreenstarBio and @EleusianBio following yesterday's acquisition announcement. $GSTR https://psilocybinalpha.com/news/interview-with-greenstar-biosciences-and-eleusian-biosciences-following-acquisition-announcement https://psilocybinalpha.com/news/interview-with-greenstar-biosciences-and-eleusian-biosciences-following-acquisition-announcement"
X Link 2020-06-17T21:18Z 20.5K followers, [--] engagements
"This week we learned of [--] psychedelic companies that are going public: π Field Trip π Silo Wellness π Eleusian Biosciences"
X Link 2020-06-19T19:49Z 20K followers, [--] engagements
"The US OTC ticker for Numinus appears to have changed to $LKYSF (previously $LKYSD) Readers who are having trouble executing orders via TD Ameritrade for example may wish to try using LKYSF. $NUMI"
X Link 2020-06-22T21:54Z 20.3K followers, [--] engagements
"π¦Private Financing Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-announces-private-placement-financing-of-up-to-1-5-million https://psilocybinalpha.com/news/hollister-biosciences-inc-announces-private-placement-financing-of-up-to-1-5-million"
X Link 2020-07-02T21:39Z 20.5K followers, [--] engagements
"Hollister Biosciences' private placement: $0.085 per share Warrants @ $0.10 for [--] months $HOLL currently trading at $0.11"
X Link 2020-07-02T21:47Z 20.4K followers, [--] engagements
"You can now browse the latest news by Company name. $NUMI $SHRM $MMED $TRIP $BUZZ $MYCO $RVV $HOLL and more. Try it here: https://psilocybinalpha.com/news https://psilocybinalpha.com/news"
X Link 2020-07-18T19:10Z 20.4K followers, [--] engagements
"π° GreenStar Biosciences Acquires Eleusian Biosciences Eleusian is acquired by GreenStar for approximately $3m via common share issuance. Transaction expected to close by August [--]. $GSTR $GTSIF https://psilocybinalpha.com/news/greenstar-biosciences-signs-definitive-agreement-to-acquire-100-of-eleusian-biosciences-corp https://psilocybinalpha.com/news/greenstar-biosciences-signs-definitive-agreement-to-acquire-100-of-eleusian-biosciences-corp"
X Link 2020-07-21T19:58Z 20.6K followers, [--] engagements
"GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences $GSTR $GTSIF https://psilocybinalpha.com/news/greenstar-biosciences-announces-filing-of-third-provisional-patent-application-by-eleusian-biosciences https://psilocybinalpha.com/news/greenstar-biosciences-announces-filing-of-third-provisional-patent-application-by-eleusian-biosciences"
X Link 2020-07-24T13:42Z 20.5K followers, [--] engagements
"π° Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing The Company sold 17.6mm units at a price of $0.085 each for gross proceeds of approx. $1.5mm. The current stock price of HOLL is $0.14. $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-closes-1-5-million-private-placement-financing https://psilocybinalpha.com/news/hollister-biosciences-inc-closes-1-5-million-private-placement-financing"
X Link 2020-08-11T08:51Z 20.5K followers, [--] engagements
"Hollister Biosciences Inc. Reports Second Quarter [----] Results Net income for the three-month period ended June 30th [----] was $0.3 million compared to a net loss of $2.1 million in the first quarter of [----] $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-inc-reports-second-quarter-2020-results https://psilocybinalpha.com/news/hollister-biosciences-inc-reports-second-quarter-2020-results"
X Link 2020-08-24T12:13Z 20.5K followers, [--] engagements
"Hollister Biosciences Retains Renmark Financial Communications Inc. to handle its investor relations activities. $HOLL $HSTRF https://psilocybinalpha.com/news/hollister-biosciences-retains-renmark-financial-communications-inc https://psilocybinalpha.com/news/hollister-biosciences-retains-renmark-financial-communications-inc"
X Link 2020-09-11T22:58Z 20.5K followers, [--] engagements
"Today's gainers: $CMPS +10.4% $HOLL +10% $FTRP +9.1% $NUMI +2.9%"
X Link 2020-10-13T22:09Z 20.4K followers, [--] engagements
"Our Weekly Psychedelics Bulletin MindMed raises $28.75m Entheon inches closer to go-public next Tuesday sees voters decide on decriminalisation in two US states. Including news from: $MMED $FTRP $SHRM $HAVN $HOLL https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-raises-28-75m-entheon-inches-closer-to-go-public-next-weeks-votes-on-decriminalisation https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-raises-28-75m-entheon-inches-closer-to-go-public-next-weeks-votes-on-decriminalisation"
X Link 2020-10-30T20:56Z 20.4K followers, [--] engagements
"Champignon Brands Announces New CFO and New General Counsel $SHRM $SHRMF https://psilocybinalpha.com/news/champignon-brands-announces-new-cfo-and-new-general-counsel https://psilocybinalpha.com/news/champignon-brands-announces-new-cfo-and-new-general-counsel"
X Link 2021-01-11T12:53Z 20.3K followers, [--] engagements
"A strong day for most psychedelics stocks. $CMPS +0.3% $MMED +11.4% $NUMI +14.1% $SHRMF -1.7% $CYBN -5.4% $FTRP +5.1% $MYCO +3.8% $HAVN +7.9% $ENBI +20.2% $TRYP +9.9%"
X Link 2021-01-21T23:31Z 20.3K followers, [--] engagements
"Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression $SHRM $SHRMF https://psilocybinalpha.com/news/champignon-brands-canadian-rapid-treatment-center-of-excellence-opens-first-community-based-centre-in-ottawa-to-provide-ketamine-treatment-for-adults-with-depression https://psilocybinalpha.com/news/champignon-brands-canadian-rapid-treatment-center-of-excellence-opens-first-community-based-centre-in-ottawa-to-provide-ketamine-treatment-for-adults-with-depression"
X Link 2021-01-25T12:54Z 20.3K followers, [--] engagements
"Psychedelics Stock Top Gainers - Feb 16th [----] $TRYP +21.2% $LOBE +13.3% $NEON +7.6% $ENBI +6.2% $MMED +4.9% $NUMI +3.9% $FTRP +3.1% $HAVN +3.0% $SHRMF +2.7%"
X Link 2021-02-16T22:46Z 20.3K followers, [--] engagements
"PsyBio Completes Reverse Take-Over Transaction Expected to list on the TSXV under ticker symbol $PSYB. https://psilocybinalpha.com/news/psybio-completes-reverse-take-over-transaction https://psilocybinalpha.com/news/psybio-completes-reverse-take-over-transaction"
X Link 2021-02-19T20:54Z 20.3K followers, [--] engagements
"Your Weekly Psychedelic Bulletin - Field Trip raising $83m - NYU Langone Officially Launches Psychedelic Medicine Center - MDMA for Alcohol Use Disorder; DMT for Kidney Transplant - and more inc. news from $FTRP $MMED $PSYB $NOVA $MSET $TRIP https://psilocybinalpha.com/news/psychedelic-bulletin-field-trip-raising-83m-nyu-langone-launches-psychedelic-medicine-center-the-many-applications-of-dmt https://psilocybinalpha.com/news/psychedelic-bulletin-field-trip-raising-83m-nyu-langone-launches-psychedelic-medicine-center-the-many-applications-of-dmt"
X Link 2021-02-26T22:02Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research Development and Manufacturing Organization https://psilocybinalpha.com/news/psybio-therapeutics-initiates-pilot-scale-development-of-proprietary-biosynthetic-psilocybin-with-global-contract-research-development-and-manufacturing-organization https://psilocybinalpha.com/news/psybio-therapeutics-initiates-pilot-scale-development-of-proprietary-biosynthetic-psilocybin-with-global-contract-research-development-and-manufacturing-organization"
X Link 2021-03-02T13:45Z 20.3K followers, [--] engagements
"Psychedelic Stocks Performance 9th March [----] $PSYK +7.7% $CMPS +12% $MMED +3.4% $NUMI +3.8% $SHRMF +5.7% $CYBN +.69% $FTRP +9.7% $MYCO +6.1% $HAVN +8.5%"
X Link 2021-03-09T21:22Z 20.3K followers, [--] engagements
"Champignon Brands stock is up 75% on its re-commencing of trading on the CSE today. $SHRM $SHRMF"
X Link 2021-04-23T15:38Z 20.3K followers, [--] engagements
"Psychedelic Bulletin 23rd April [----] MindMed $MMED to list on the Nasdaq Atai Life Sciences to IPO Champignon Brands $SHRM $SHRMF Resumes Trading . and more from $RVV $CYBN $PHRM https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-to-list-on-nasdaq-atai-ipo-unveiled-champignon-brands-resumes-trading https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-to-list-on-nasdaq-atai-ipo-unveiled-champignon-brands-resumes-trading"
X Link 2021-04-23T17:00Z 20.3K followers, [--] engagements
"PsyBio $PSYB and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform Expediting its IND Submission to the FDA https://psilocybinalpha.com/news/psybio-and-miami-university-broaden-partnership-agreement-for-the-continued-advancement-of-its-neuropsychiatric-drug-discovery-platform-expediting-its-ind-submission-to-the-fda"
X Link 2021-04-26T18:33Z 20.3K followers, [--] engagements
"π MindMed Nasdaq Listing Poll MindMed lists on the Nasdaq today under ticker symbol $MNMD. What price will it close at $MMED $MMEDF $5 $5-$7.5 $10 $7.51 - $10 $5 $5-$7.5 $10 $7.51 - $10"
X Link 2021-04-27T10:50Z 20.3K followers, [--] engagements
"Entheon Biomedical Lists on OTCQB Venture Market under $ENTBF https://psilocybinalpha.com/news/entheon-biomedical-lists-on-otcqb-venture-market https://psilocybinalpha.com/news/entheon-biomedical-lists-on-otcqb-venture-market"
X Link 2021-05-05T15:10Z 20.3K followers, [--] engagements
"Wesana Health Commences Trading on the CSE Ticker symbol $WESA https://psilocybinalpha.com/news/wesana-health-commences-trading-on-the-cse https://psilocybinalpha.com/news/wesana-health-commences-trading-on-the-cse"
X Link 2021-05-10T11:45Z 20.6K followers, [--] engagements
"Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market $FTRP $FTRPF https://psilocybinalpha.com/news/field-trip-health-ltd-applies-to-list-its-common-shares-on-the-nasdaq-stock-market https://psilocybinalpha.com/news/field-trip-health-ltd-applies-to-list-its-common-shares-on-the-nasdaq-stock-market"
X Link 2021-06-08T12:18Z 20.3K followers, [--] engagements
"MindMed Appoints Pharmaceutical Veteran Peter Bergethon M.D. to Scientific Advisory Board Dr. Bergethon is the Vice President and Head of Digital and Quantitative Medicine at Biogen Inc. $MMED $MNMD https://psilocybinalpha.com/news/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-m-d-to-scientific-advisory-board https://psilocybinalpha.com/news/mindmed-appoints-pharmaceutical-veteran-peter-bergethon-m-d-to-scientific-advisory-board"
X Link 2021-06-17T11:41Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Subsidiary HaluGen Life Sciences Announces Agreement with Third Wave https://psilocybinalpha.com/news/entheon-biomedical-subsidiary-halugen-life-sciences-announces-agreement-with-third-wave https://psilocybinalpha.com/news/entheon-biomedical-subsidiary-halugen-life-sciences-announces-agreement-with-third-wave"
X Link 2021-06-22T13:43Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds including Psilocybin with France-based Biose Industrie https://psilocybinalpha.com/news/psybio-therapeutics-initiates-european-manufacturing-of-proprietary-biosynthetic-psychedelic-compounds-including-psilocybin-with-france-based-biose-industrie https://psilocybinalpha.com/news/psybio-therapeutics-initiates-european-manufacturing-of-proprietary-biosynthetic-psychedelic-compounds-including-psilocybin-with-france-based-biose-industrie"
X Link 2021-06-22T17:42Z 20.3K followers, [--] engagements
"Entheon Biomedical Corp. $ENBI Acquires Lobo Genetics Inc. Company acquires second genetic screening asset. https://psilocybinalpha.com/news/entheon-biomedical-corp-acquires-lobo-genetics-inc https://psilocybinalpha.com/news/entheon-biomedical-corp-acquires-lobo-genetics-inc"
X Link 2021-07-30T12:10Z 20.3K followers, [--] engagements
"Psychedelics Bulletin July [--] [----] MindMed initiates DMT trial $MNMD ( $DMT $ATAI and $ENBI also exploring DMT) COMPASS Pathways appoints CMO $CMPS Field Trip lists on NASDAQ $FTRP . and more. https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-initiates-dmt-trial-compass-appoints-cmo-field-trip-lists-on-nasdaq https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-initiates-dmt-trial-compass-appoints-cmo-field-trip-lists-on-nasdaq"
X Link 2021-07-30T17:57Z 20.3K followers, [--] engagements
"PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs $PSYB https://psilocybinalpha.com/news/psybio-therapeutics-files-patent-application-with-uspto-for-production-methods-of-methylated-trypatamines-and-associated-analogs https://psilocybinalpha.com/news/psybio-therapeutics-files-patent-application-with-uspto-for-production-methods-of-methylated-trypatamines-and-associated-analogs"
X Link 2021-08-16T18:37Z 20.3K followers, [--] engagements
"Charles Nichols on HaluGen's (Entheon subsidiary $ENBI) psychedelics genetic test: The premise of trying to link one polymorphism with a behavioral predictor is just I would say preposterous. https://www.vice.com/en/article/y3d4xb/genetic-testing-predict-bad-psychedelic-trip-halugen https://www.vice.com/en/article/y3d4xb/genetic-testing-predict-bad-psychedelic-trip-halugen"
X Link 2021-08-20T13:48Z 20.3K followers, [--] engagements
"#Psychedelics Bulletin August [--] [----] Beckley Psytech raises $80m in Series B round Bright Minds $DRUG share positive preclinical findings HaluGen's psychedelics DNA test called into question $ENBI . and more. https://psilocybinalpha.com/news/psychedelic-bulletin-beckley-psytech-raises-80m-in-series-b-bright-minds-biosciences-reports-positive-preclinical-findings-psychedelics-dna-test-called-into-question"
X Link 2021-08-20T19:55Z 20.3K followers, [--] engagements
"Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon $ENBI Advisory Board "Dr. David Erritzoe to provide guidance on psychopharmacological research" https://psilocybinalpha.com/news/clinical-director-of-imperial-colleges-center-for-psychedelic-research-joins-entheon-advisory-board https://psilocybinalpha.com/news/clinical-director-of-imperial-colleges-center-for-psychedelic-research-joins-entheon-advisory-board"
X Link 2021-08-25T12:35Z 20.3K followers, [--] engagements
"Wesana Health $WESA Announces Closing of PsyTech Acquisition https://psilocybinalpha.com/news/wesana-health-announces-closing-of-psytech-acquisition https://psilocybinalpha.com/news/wesana-health-announces-closing-of-psytech-acquisition"
X Link 2021-09-09T14:31Z 20.6K followers, [--] engagements
"Citigroup Top Stock Picks Range From Psychedelic Drugs to NFTs The bank's Disruptive Innovations report included psychedelics citing $ATAI and $CMPS in particular. https://www.bloomberg.com/news/articles/2021-10-12/citigroup-turns-to-psychedelic-drugs-nfts-for-investment-picks https://www.bloomberg.com/news/articles/2021-10-12/citigroup-turns-to-psychedelic-drugs-nfts-for-investment-picks"
X Link 2021-10-12T16:16Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Provides Corporate Update on Studies and Clinical Trials https://psilocybinalpha.com/news/entheon-biomedical-provides-corporate-update-on-studies-and-clinical-trials https://psilocybinalpha.com/news/entheon-biomedical-provides-corporate-update-on-studies-and-clinical-trials"
X Link 2021-10-27T12:55Z 20.3K followers, [--] engagements
"Psychedelics Bulletin Oct [--] [----] MindMed announces R(-)-MDMA program Psilocybin for anxiety study secures ethics approval UCL joins the renaissance: @PsychedelicUNIT + more from: $CYBN $DMT $MYND $SILO $AWKN $ENBI $MCUR $MYCO $NOVA $PHRM https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-announces-r-mdma-program-psilocybin-for-anxiety-study-secures-ethics-approval-ucl-joins-the-renaissance https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-announces-r-mdma-program-psilocybin-for-anxiety-study-secures-ethics-approval-ucl-joins-the-renaissance"
X Link 2021-10-29T19:49Z 20.3K followers, [--] engagements
"Numinus OTC Ticker Change $LKYSF - $NUMIF https://psilocybinalpha.com/news/numinus-to-begin-trading-on-the-otc-under-symbol-numif https://psilocybinalpha.com/news/numinus-to-begin-trading-on-the-otc-under-symbol-numif"
X Link 2021-11-19T13:36Z 20.3K followers, [--] engagements
"PsyBio Therapeutics $PSYB Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications "Intellectual Property Filing and Protection Remains a Top Priority" https://psilocybinalpha.com/news/psybio-therapeutics-furthers-intellectual-property-portfolio-with-six-new-manufacturing-patent-applications https://psilocybinalpha.com/news/psybio-therapeutics-furthers-intellectual-property-portfolio-with-six-new-manufacturing-patent-applications"
X Link 2021-11-19T17:32Z 20.3K followers, [--] engagements
"Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences Participants Receive First Doses of Psilocybin $BRAX https://psilocybinalpha.com/news/braxia-scientific-achieves-milestone-as-landmark-psilocybin-clinical-trial-commences-participants-receive-first-doses-of-psilocybin https://psilocybinalpha.com/news/braxia-scientific-achieves-milestone-as-landmark-psilocybin-clinical-trial-commences-participants-receive-first-doses-of-psilocybin"
X Link 2021-12-14T13:07Z 20.3K followers, [--] engagements
"Entheon Biomedical $ENBI Announces Expanded Psychedelics Genetic Test Panel "Subsidiary HaluGen Life Sciences has expanded its genetic test panel to include the CYP2D6 gene a marker indicating the metabolism of LSD MDMA and ayahuasca" https://psilocybinalpha.com/news/entheon-biomedical-announces-expanded-psychedelics-genetic-test-panel https://psilocybinalpha.com/news/entheon-biomedical-announces-expanded-psychedelics-genetic-test-panel"
X Link 2021-12-22T10:40Z 20.3K followers, [--] engagements
"Entheon Biomedical $ENBI Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee https://psilocybinalpha.com/news/entheon-biomedical-provides-update-on-dmt-human-trial-and-announces-regulatory-submission-to-ethics-committee https://psilocybinalpha.com/news/entheon-biomedical-provides-update-on-dmt-human-trial-and-announces-regulatory-submission-to-ethics-committee"
X Link 2022-01-06T14:17Z 20.3K followers, [--] engagements
"Wesana Health Granted US FDA Pre-IND Meeting for SANA-013 $WESA https://psilocybinalpha.com/news/wesana-health-granted-us-fda-pre-ind-meeting-for-sana-013 https://psilocybinalpha.com/news/wesana-health-granted-us-fda-pre-ind-meeting-for-sana-013"
X Link 2022-01-11T13:24Z 20.6K followers, [--] engagements
"Wesana Health $WESA Provides Strategic and Operational Updates https://psilocybinalpha.com/news/wesana-health-provides-strategic-and-operational-updates https://psilocybinalpha.com/news/wesana-health-provides-strategic-and-operational-updates"
X Link 2022-01-12T13:25Z 20.6K followers, [--] engagements
"BC Craft Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada) Are we starting to see bankruptcy proceedings of the first few loosely-defined psychedelics company https://www.globenewswire.com/news-release/2022/01/25/2373047/0/en/BC-Craft-Has-Filed-Notice-of-Intention-to-Make-a-Proposal-Under-the-Bankruptcy-Insolvency-Act-Canada.html https://www.globenewswire.com/news-release/2022/01/25/2373047/0/en/BC-Craft-Has-Filed-Notice-of-Intention-to-Make-a-Proposal-Under-the-Bankruptcy-Insolvency-Act-Canada.html"
X Link 2022-01-26T13:12Z 20K followers, [--] engagements
"Entheon Biomedical $ENBI Partners with Wavepaths on Upcoming Observational Study Study is taking place at Heading Health. https://psilocybinalpha.com/news/entheon-biomedical-partners-with-wavepaths-on-upcoming-observational-study https://psilocybinalpha.com/news/entheon-biomedical-partners-with-wavepaths-on-upcoming-observational-study"
X Link 2022-02-16T13:33Z 20.3K followers, [--] engagements
"Entheon Biomedical Announces Non-Brokered Private Placement Financing Units priced at C$0.10 for gross proceeds up to C$3m $ENBI which was trading at C$0.18 this time last month today trades at C$0.12 walking down toward the offering price. https://psilocybinalpha.com/news/entheon-biomedical-announces-non-brokered-private-placement-financing https://psilocybinalpha.com/news/entheon-biomedical-announces-non-brokered-private-placement-financing"
X Link 2022-04-05T16:44Z 20.3K followers, [--] engagements
"Cybin Acquires DMT Clinical Study from Entheon Biomedical $CYBN has acquired a Phase [--] DMT study from $ENBI. "The Phase [--] EBRX-101 study now named CYB004-E is being conducted in the Netherlands at the Centre for Human Drug Research." https://www.businesswire.com/news/home/20220606006028/en/ https://www.businesswire.com/news/home/20220606006028/en/"
X Link 2022-06-07T12:34Z 20.3K followers, [--] engagements
"Psychedelic Bulletin #119 π More Misery for MindMed $MNMD π¦ Onsero Looks to Skip the Trip β No Safe $HAVN: Another Psychedelics Company Grinds to a Halt β An Update on Terran vs Compass $CMPS π A Very Brief Dispatch from ICPR & more. https://psychedelicalpha.com/news/psychedelic-bulletin-119-more-misery-for-mindmed-another-psychedelics-co-ceases-operations-a-brief-dispatch-from-icpr https://psychedelicalpha.com/news/psychedelic-bulletin-119-more-misery-for-mindmed-another-psychedelics-co-ceases-operations-a-brief-dispatch-from-icpr"
X Link 2022-09-30T23:20Z 20.3K followers, [--] engagements
"Half of All Public Psychedelics Companies at Risk of Running out of Cash This Year According to our data 1/2 have already run out of cash or are set to do so by the end of [----]. Unless financings take place or cash burn slows significantly it's the end of the road"
X Link 2022-10-27T15:32Z 20.3K followers, [--] engagements
""Field Trip Health will be offering their services free of charge to people who got laid off from a host of companiesincluding Twitter Meta Stripe and others." $FTHW https://fortune.com/well/2022/11/30/laid-off-workers-free-ketamine-assisted-therapy-services-field-trip/ https://fortune.com/well/2022/11/30/laid-off-workers-free-ketamine-assisted-therapy-services-field-trip/"
X Link 2022-11-30T16:49Z 20.3K followers, [--] engagements
"Numinus $NUMI Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea Trainee therapists will ingest tea brewed with whole Psilocybe mushrooms. https://psychedelicalpha.com/news/numinus-receives-clinical-trial-application-approval-from-health-canada-for-experiential-psychedelic-assisted-therapy-training-using-psilocybe-cubensis-tea"
X Link 2023-02-01T15:48Z 20K followers, [---] engagements
"BREAKING: Reunion Neuroscience Files Lawsuit Against Mindset Pharma $REUN alleges that $MSET knowingly copied Reunions RE104 compound and misleadingly presented that exact composition while applying for U.S. Patent No. [--------] https://psychedelicalpha.com/news/reunion-neuroscience-files-lawsuit-against-mindset-pharma https://psychedelicalpha.com/news/reunion-neuroscience-files-lawsuit-against-mindset-pharma"
X Link 2023-03-13T23:01Z 20.3K followers, [----] engagements
"FT: US clinic offers ketamine therapy to treat alcoholism "UK biotech Awakn licences party drug to addiction clinics" $AWKN https://www.ft.com/content/2d142cff-1a92-4652-b2d7-86c29ab9566c https://www.ft.com/content/2d142cff-1a92-4652-b2d7-86c29ab9566c"
X Link 2023-03-14T19:49Z 20.3K followers, [----] engagements
"BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations Chicago Washington DC Seattle San Diego Fredericton "The anticipated last day of operation for each of these locations will be on or around April [--] 2023." $FTHW https://finance.yahoo.com/news/field-trip-health-wellness-close-125000229.html https://finance.yahoo.com/news/field-trip-health-wellness-close-125000229.html"
X Link 2023-03-15T13:36Z 20.3K followers, [----] engagements
"Field Trip Shutters Majority of its Clinics According to the company's most recent deck $FTHW operates [--] clinics in North America ("and growing"). The closure of these [--] locations which will happen in around a month represents the majority of its physical presence. BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations Chicago Washington DC Seattle San Diego Fredericton "The anticipated last day of operation for each of these locations will be on or around April [--] 2023." $FTHW https://t.co/bKypWL4MCx BREAKING: Field Trip Health & Wellness to Close Clinics in [--] Locations"
X Link 2023-03-15T13:45Z 20.3K followers, [----] engagements
"Analysis: Reunion Neuroscience Sues Mindset Pharma Claims it Copied RE104 Inside: π
A timeline of key events β The strength (or lack thereof) of $REUN's lawsuit against $MSET πΊ Broader context Will this lawsuit lead to a reunion with karma https://psychedelicalpha.com/news/reunion-sues-mindset-claims-it-copied-re104 https://psychedelicalpha.com/news/reunion-sues-mindset-claims-it-copied-re104"
X Link 2023-03-15T18:16Z 20.3K followers, [----] engagements
"Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery $WESA's SANA-13 is a combination of psilocybin and cannabidiol. Sale to $LSDI expected to complete in Q2. https://psychedelicalpha.com/news/wesana-health-announces-sale-of-sana-13-assets-to-lucy-scientific-discovery https://psychedelicalpha.com/news/wesana-health-announces-sale-of-sana-13-assets-to-lucy-scientific-discovery"
X Link 2023-03-21T16:56Z 20.3K followers, [---] engagements
"Update: Field Trip Shares Suspended Trading CEO Resigns CEO and co-founder Ronan Levy has resigned replaced by a Chief Restructuring Officer. Field Trip has obtained creditor protection under the CCAA. Trading of $FTHW has been suspended. https://psychedelicalpha.com/news/field-trip-health-wellness-obtains-ccaa-protection Field Trip Shutters Majority of its Clinics According to the company's most recent deck $FTHW operates [--] clinics in North America ("and growing"). The closure of these [--] locations which will happen in around a month represents the majority of its physical presence."
X Link 2023-03-22T20:14Z 20.3K followers, 20.8K engagements
"Field Trips Downfall: Too Early Too Aggressive Too Extravagant We dig through pitch decks interviews and data to piece together a trip report that saw Field Trip $FTHW go from loud brash market leader to all-but bankrupt. https://psychedelicalpha.com/news/field-trips-downfall-too-early-too-aggressive-too-extravagant https://psychedelicalpha.com/news/field-trips-downfall-too-early-too-aggressive-too-extravagant"
X Link 2023-03-28T14:36Z 20.3K followers, [--] engagements
"Are psychedelic medicines the reset for chronic pain "Psychedelics may improve functionality and quality of life in chronic pain patients." "The therapeutic potential of psychedelics for chronic pain warrants expanded research." https://www.sciencedirect.com/science/article/abs/pii/S0028390823001181via%3Dihub https://www.sciencedirect.com/science/article/abs/pii/S0028390823001181via%3Dihub"
X Link 2023-04-05T11:22Z 20.3K followers, [----] engagements
"Awakn $AWKN Provides Corporate Update Among the updates: Dr. Ben Sessa has resigned from his role as Head of Psychedelic Medicine at Awakn. https://www.newsfilecorp.com/release/162112/Awakn-Life-Sciences-Increases-Ownership-of-Awakn-Bristol-to-100-and-Provides-Corporate-Update https://www.newsfilecorp.com/release/162112/Awakn-Life-Sciences-Increases-Ownership-of-Awakn-Bristol-to-100-and-Provides-Corporate-Update"
X Link 2023-04-12T15:43Z 20.3K followers, [---] engagements
"Psychedelic Bulletin #139 π Paper Claims Psychedelics Exert Antidepressant Effects By Binding to TrkB Not 5-HT2A π΅ $42 Million for Ibogaine Research π Reunion $REUN Announces Take-Private Transaction π§ $CMPS Patents Upheld and more. https://psychedelicalpha.com/news/psychedelic-bulletin-139-kentucky-earmarks-42m-for-ibogaine-studies-reunion-announces-take-private-deal-compass-patents-upheld-theories-of-psychedelics-mechanism-of-action"
X Link 2023-06-14T21:41Z 20.3K followers, [---] engagements
"The recent legalisation of psychedelic-assisted therapy for post-traumatic stress disorder and treatment-resistant depression has the potential of providing people with an alternative means of care at the end of our lives"
X Link 2023-07-11T09:49Z 19.5K followers, [---] engagements
"Legalizing psychedelics could become a ballot question in Massachusetts "Massachusetts has the opportunity to lead the way in the mental health revolution" Southwick Republican Rep. Nicholas Boldyga told his colleagues"
X Link 2023-07-11T14:10Z 19.4K followers, [---] engagements
"Do psychedelics treat chronic pain or is it the placebo effect "Preliminary studies show that psilocybin a compound in magic mushrooms reduces pain in people with chronic Lyme disease fibromyalgia and migraines." https://www.newscientist.com/article/2381495-do-psychedelics-treat-chronic-pain-or-is-it-the-placebo-effect/ https://www.newscientist.com/article/2381495-do-psychedelics-treat-chronic-pain-or-is-it-the-placebo-effect/"
X Link 2023-07-12T15:13Z 20.3K followers, [----] engagements
""Last year Dr. Bronners released a midterm voter guide with a list of [--] state and local ballot initiatives the company felt strongly about such as decriminalizing psychedelics and increasing taxes on the rich.""
X Link 2023-07-12T19:03Z 19.5K followers, 11.7K engagements
"House poised to OK psychedelics for military trauma thanks to Crenshaw-AOC partnership "The ex-Navy SEAL from Houston and Ocasio-Cortez a New York democratic socialist extol psilocybin to treat PTSD depression and addiction.""
X Link 2023-07-14T15:55Z 19.4K followers, [----] engagements
"Could psychedelics simultaneously treat chronic pain and depression ".undergraduate Ahmad Hammo is spending the summer alongside Joseph Cichon . investigating the potential for psilocybin to treat chronic neuropathic pain." https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression https://penntoday.upenn.edu/news/could-psychedelics-simultaneously-treat-chronic-pain-and-depression"
X Link 2023-08-01T09:27Z 20.3K followers, [----] engagements
"MindMed has secured a $50m credit facility $15m was drawn at closing. Together with $MNMD cash on hand the company expects to fund operations into [----]. https://www.businesswire.com/news/home/20230814596096/en/MindMed-Secures-50.0-Million-Credit-Facility-with-K2-HealthVentures https://www.businesswire.com/news/home/20230814596096/en/MindMed-Secures-50.0-Million-Credit-Facility-with-K2-HealthVentures"
X Link 2023-08-14T12:49Z 19.9K followers, [----] engagements
"Psychedelic drug therapy: Just say yes "CONGRESS WARMS TO PSYCHEDELIC DRUGS Psychedelic medicine is forging unexpected alliances in Washington.""
X Link 2023-08-14T14:30Z 19.4K followers, [----] engagements
"Psychedelics Are Reaching New Highs in Acceptance and Businesses Want In "Once seen as taboo psychedelics are being recognized for their medicinal potential in treating some mental health ailments." https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html https://www.inc.com/melissa-angell/psychedelics-are-reaching-new-highs-in-acceptance-businesses-want-in.html"
X Link 2023-08-16T15:03Z 20K followers, [----] engagements
"Former Director of Strategy & Operations Brings Complaint Against MindMed The complaint alleges among other things that the company is a "boy's club" with Plaintiff Madeline Feldman withstanding "years of unequal pay and harassment""
X Link 2023-08-25T15:49Z 19.9K followers, [---] engagements
"Ottawa police shut down store selling illegal magic mushrooms in Centretown "Police say despite the execution of the warrant and notification from the property owner to cease any unlawful activity last Friday the store re-opened for business this week.""
X Link 2023-08-25T16:01Z 19.5K followers, [---] engagements
"BREAKING: Cybin to Acquire Small Pharma Inc. $CYBN will acquire $DMT in an all-share transaction"
X Link 2023-08-28T14:52Z 19.4K followers, [--] engagements
"BREAKING: Otsuka to Acquire Mindset Pharma $MSET"
X Link 2023-08-31T12:33Z 20.3K followers, [----] engagements
"Big Pharma Company Otsuka to Buy Mindset Pharma Toronto-based Mindset Pharma $MSET is set to be acquired by the U.S. arm of Otsuka Pharmaceutical in an all-cash transaction valued at around CAD $80m (around USD $60m). https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m https://psychedelicalpha.com/news/breaking-big-pharma-company-otsuka-to-acquire-mindset-pharma-for-cad-80m"
X Link 2023-08-31T12:40Z 20.3K followers, [----] engagements
"How does psilocybin-assisted therapy work in Colorado and Oregon "Regulators are still crafting rules for Colorado but standards have emerged underground and in Oregon""
X Link 2023-09-04T11:17Z 19.4K followers, [---] engagements
"I cured my ARFID with psilocybin. I shouldnt have needed to self-treat it "In August I self-administered a therapeutic dose of psilocybin mushrooms and intentionally ate a dozen new-to-me foods during my psychedelic trip.""
X Link 2023-09-06T09:50Z 19.5K followers, [----] engagements
"California Assembly passes psychedelics decriminalization bill (SB 58) 43-15 vote Now returns to Senate for final sign-off before heading to the Governor's desk"
X Link 2023-09-07T08:23Z 19.2K followers, [----] engagements
"MindMed Sues $100 Million Meme Stock Trader Over Proxy Bid $MNMD alleges that Jake Freeman issued misleading proxy solicitations to shareholders. https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid https://news.bloomberglaw.com/litigation/mindmed-sues-100-million-meme-stock-trader-over-proxy-bid"
X Link 2023-09-08T08:20Z 19.9K followers, [---] engagements
"VC Ford Smith used psychedelics and biohacking to pull himself out of a deep depression. "In the four years that he and his firm have been focusing on the industry Smith says he's been heartened by the uptick in interest""
X Link 2023-09-08T13:21Z 19.2K followers, [---] engagements
"S-3 filed by COMPASS details potential resale of up to 40m shares of $CMPS by various shareholders most notably atai. $ATAI could sell up to [--] million COMPASS shares. However this is also standard 'corporate housekeeping' as explained on recent earnings call"
X Link 2023-09-11T13:46Z 19.5K followers, [---] engagements
"Ann Arbor welcomes psychedelic plant festival for third year "The third annual Entheofest is a free-speech event focused on decriminalizing psychedelic plants and fungi across the state of Michigan.""
X Link 2023-09-11T13:56Z 19.5K followers, [---] engagements
"Tomorrow: Exploring the Ethical and Practical Considerations of Psychedelics Research The [----] OHRP Exploratory Workshop will be live-streamed tomorrow September 14th 9:45 AM 4:15 PM EDT"
X Link 2023-09-13T16:07Z 19.5K followers, [---] engagements
"Endpoints: MAPS plans to seek approval of MDMA-assisted therapy this year after second positive PhIII trial https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial/ https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial/"
X Link 2023-09-14T16:07Z 20K followers, [----] engagements
"Is the US Ready to Release the Therapeutic Potential of Psychedelics RBC Capital Markets speaks with MindMed CEO Rob Barrow https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic https://www.rbccm.com/en/story/story.pagedcr=templatedata/article/story/data/2023/08/is-the-us-ready-to-release-the-therapeutic"
X Link 2023-09-16T11:14Z 19.9K followers, [---] engagements
"MDMA-Assisted Therapy Is One Step Closer to FDA Approval"
X Link 2023-09-20T10:34Z 19.2K followers, [----] engagements
"Bill aims to stop federal intervention in states allowing use of magic mushrooms A kind of Cole Memo for psychedelics: it would discourage federal law enforcement from intervening in states/localities that have reformed psychedelic drug policy"
X Link 2023-09-20T14:20Z 19.5K followers, [---] engagements
"California Senate Minority Leader Brian Jones Urges Governor Newsom to Veto Psychedelic Decrim. Bill (SB 58) "the idea of allowing the widespread uncontrolled and unsupervised use of these powerful drugs for self-medicating purposes is a scary prospect to many Californians""
X Link 2023-09-21T15:47Z 19.4K followers, [---] engagements
"Psychedelics Business Forum reMind Returns To Las Vegas "The event takes place at Westgate Las Vegas Resort & Casino on Nov. 28-29 as a popular pre-show forum show ahead of MJBizCon.""
X Link 2023-09-22T17:08Z 19.4K followers, [---] engagements
""Governor Newsom would be wise to sign this bill into law and other states and the federal government should follow suit.""
X Link 2023-09-28T16:33Z 19.4K followers, [---] engagements
"atai Life Sciences Announces Completion of Phase [--] Study of VLS-01in Healthy Participants atai's DMT candidate was "well-tolerated with a favorable safety profile". The company will test a "further optimized" version before initiating a Phase [--] study"
X Link 2023-10-02T20:34Z 19.2K followers, [---] engagements
"Unsealed Court Filing Reveals Email Exchange Between MindMed and Ceruvia Execs Stephen Hurst negotiated the exchange of GMP LSD with Carey Turnbull. In consideration the email contemplates a cash payment from $MNMD plus an agreement to not assert IP rights among other things"
X Link 2023-10-05T19:15Z 19.9K followers, [----] engagements
"Introducing the Psychedelic News Feed Every day we manually select news clippings research publications and commentary for inclusion: no aggregators or AI bots. Explore:"
X Link 2023-10-10T14:51Z 19.4K followers, [----] engagements
"This Senator Wants to Legalize Magic Mushrooms in Mexico @alelagunes says that psilocybin mushrooms could be a benefit to the country's mental health crisis"
X Link 2023-10-13T09:44Z 19.5K followers, [----] engagements
"Provides an overview of the company's IP which is claimed to be the "largest IP portfolio" in the psychedelic sector with [--] patents granted and over [---] pending"
X Link 2023-11-01T15:07Z 19.2K followers, [---] engagements
"Upcoming data: CYB003 Ph [--] topline efficacy data expected Q4 [----] CYB004 Ph [--] topline data in Q4 [----] Upcoming trials: [--] trials upcoming in 2024"
X Link 2023-11-01T15:08Z 19.2K followers, [---] engagements
"Now on to the CYB003 interim data which refers to cohorts [--] and 5"
X Link 2023-11-01T15:11Z 19.2K followers, [---] engagements
"Compass Pathways initiates UK component of global phase [--] study of psilocybin treatment in treatment-resistant depression and launches new research center "The COMP [---] trial will be conducted at research sites across the UK""
X Link 2023-11-15T11:41Z 19.2K followers, [---] engagements
"Psychedelic Patent Analysis This month: - MindMed scores psilocybin-antidepressant co-treatment patent - A spate of PCTs published from GH Research - Early fruits of Cybin's Small Pharma acquisition (Free P+ taster issue.) https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-october-2023"
X Link 2023-11-24T17:50Z 19.9K followers, [----] engagements
"Were at the reMind Psychedelics Business Forum in Las Vegas Discussions include psychedelic policy business harm reduction and beyond"
X Link 2023-11-28T20:10Z 19.2K followers, [---] engagements
"P+ Psychedelic Bulletin #151: Psilocybin for BDII ACNP Readouts Methylone for PTSD and More Psychedelic Drug Dev. News - Compass-Sponsored Study of Psilocybin in Bipolar Type II Finds Preliminary Safety and Efficacy - MindMed Shares Topline Results from LSD for Generalised Anxiety Disorder Study - Delix: First Look at DLX-001 Phase I Data - Intra-Cellular Therapies: Preclinical Data from Non-Hallucinogenic Psychedelics Program - Gilgamesh: Wraps Ph I Trial of GM-2505 - Cybin: Further CYB003 Data - Transcend: First Look at Ph [--] Methylone for PTSD Data and more."
X Link 2023-12-14T15:37Z 19.9K followers, [---] engagements
"Psychedelic Bulletin #152: Policy and Business Updates We review the DEA's latest psychedelic scheduling attempt psychedelics' inclusion in the NDAA Jamaica's Psilocybin Industry Working Group EMA's psychedelics Workshop in April [----] and much more"
X Link 2023-12-22T14:40Z 19.3K followers, [----] engagements
""Big Pharma Enters Psychedelics As AbbVie Buys Compass Pathways" is one of Cowen's 'Potential Surprises For 2024'. Cowen's top [--] potential surprises of [----] $XBI https://t.co/a3uziIlSrh Cowen's top [--] potential surprises of [----] $XBI https://t.co/a3uziIlSrh"
X Link 2023-12-30T07:25Z 19.4K followers, [----] engagements
"Q: Why didn't you buy the whole company A: Angermayer suggests Beckley wasn't open to full sale which he liked. Valuations in biotech are "distorted" and "super low" he said hinting part of motivation. Rao and Brand meanwhile keen to emphasise the data was the motivation"
X Link 2024-01-04T13:41Z 19.2K followers, [---] engagements
"BREAKING: MAPS PBC Closes $100m Series A Rebrands to Lykos Therapeutics We take a closer look at MAPS PBCs Series A rebrand to Lykos and what this might tell us about an organisation that so desperately wants to do things differently"
X Link 2024-01-05T13:01Z 19.4K followers, 19.1K engagements
"Magnesiumibogaine therapy in veterans with traumatic brain injuries A heavily-anticipated open-label study from Nolan Williams et al. was published today. ".resulted in significant improvements" in functioning PTSD depression and anxiety"
X Link 2024-01-05T14:11Z 19.5K followers, [----] engagements
"It's been a busy start to [----]. π€ atai scoops up 35.5% of Beckley Psytech via $50m investment π° MAPS PBC raises $100m Series A rebrands to Lykos Therapeutics π VA announces it will fund psychedelic research for first time since '60s .and more"
X Link 2024-01-05T20:10Z 19.5K followers, [---] engagements
"Psychedelics Are Going Mainstream. Investing in Them Hasnt. "Drugs like LSD have shown potential for treating psychiatric disorders. Wall Street and big pharma arent convinced.""
X Link 2024-01-06T15:41Z 19.2K followers, [---] engagements
"MindMed Scraps Sub-Perceptual LSD Program After ADHD Study Failed $MNMD will not develop its microdosing regimen of LSD any further as a PoC study of repeated sub-perceptual doses (20 g) in adults with ADHD failed to meet its primary endpoint. https://www.businesswire.com/news/home/20240108449557/en/MindMed-Announces-Business-Update-and-Anticipated-Milestones-for-2024 https://www.businesswire.com/news/home/20240108449557/en/MindMed-Announces-Business-Update-and-Anticipated-Milestones-for-2024"
X Link 2024-01-08T16:28Z 19.9K followers, [----] engagements
"SCOOP: The Obscure Advisory Panel Blocking Dozens of Psychedelic Studies in California Dozens of psychedelics are stuck in limbo despite being cleared by FDA DEA etc. costing $ millions and preventing new studies launching. Read our coverage:"
X Link 2024-01-09T14:40Z 19.4K followers, 10.2K engagements
"8. MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics Josh was invited to give a short presentation at the inaugural meeting of a psychedelics MEP Action Group at the European Parliament in Brussels"
X Link 2024-01-11T15:57Z 19.4K followers, [---] engagements
"9. P+: A Nue Lease of Life Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health We piece together the trajectory: from a buoyant Series A through a series of pivots and rumours of bankruptcy"
X Link 2024-01-11T15:57Z [--] followers, [---] engagements
"10. MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD Our shortest popular story of the year was the breaking news that MAPS PBC (now Lykos) had filed a New Drug Application (NDA) for MDMA-Assisted Therapy for PTSD with the FDA"
X Link 2024-01-11T15:57Z 19.4K followers, [---] engagements
"Psychedelic Bulletin #153 MindMed Scraps LSD Microdosing Ibogaine in TBI Study Compass' Research Collab. with Greenbrook Preclinical Results: Gilgameshs GM-1020 Cybin Shares Topline dDMT Data atai's EMP-01 Ph I Readout and more. https://psychedelicalpha.com/news/psychedelic-bulletin-153-mindmed-scraps-microdosing-program-eagerly-anticipated-ibogaine-study-publishes-compass-collaborates-with-greenbrook-gilgameshs-gm-1020-readout-and-more"
X Link 2024-01-12T13:41Z 19.9K followers, [----] engagements
"Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health The news comes just two weeks afterCompass announced a research collaboration withGreenbrook TMS. https://www.globenewswire.com/news-release/2024/01/16/2809793/0/en/Compass-Pathways-enters-into-research-collaboration-agreement-with-Hackensack-Meridian-Health-to-develop-optimal-clinical-model-for-investigational-COMP360-psilocybin-treatment-if-.html"
X Link 2024-01-16T13:21Z 19.9K followers, [---] engagements
"When ordered by marketcap we see that $CMPS $ATAI and $GHRS are the largest public psychedelics companies. This was true for [----] too"
X Link 2024-01-18T16:43Z 19.4K followers, [---] engagements
"Our report also includes case studies of individual psychedelics stocks. Cybin's for example appreciated significantly following its announcement of the Small Pharma acquisition"
X Link 2024-01-18T16:43Z 19.4K followers, [---] engagements
""We support the decriminalization of psychedelic use and the protection of Indigenous practices but we believe that policies such as Oregons outpace evidence on psilocybins safety" - Paul Appelbaum William Smith and Dominic Sisti"
X Link 2024-01-18T17:17Z 19.4K followers, [---] engagements
"Psychedelics M&A and Partnerships in [----] We review 2023's mergers acquisitions and partnerships in the psychedelics industry including Otsuka's purchase of Mindset Pharma and Cybin's acquisition of Small Pharma. https://psychedelicalpha.com/news/psychedelics-ma-and-partnerships-in-2023 https://psychedelicalpha.com/news/psychedelics-ma-and-partnerships-in-2023"
X Link 2024-01-22T14:48Z 20K followers, [---] engagements
""expectancy for escitalopram was associated with improved therapeutic outcomes to escitalopram but expectancy for psilocybin was not predictive of response to psilocybin""
X Link 2024-01-23T12:41Z 19.4K followers, [----] engagements
"Investors pile into psychedelic drug start-ups tackling mental health "Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing mind-altering substances""
X Link 2024-02-10T13:08Z 19.5K followers, [----] engagements
"One of the at-home ketamine industry's biggest boosters has turned bearish. Juan Pablo Cappello who raised (and spent) tens of millions as CEO of Nue Life Health is now concerned that the profit motive can lead to poor patient outcomes"
X Link 2024-03-04T16:42Z 19.6K followers, [----] engagements
"FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase [--] Program Plans Our coverage: https://psychedelicalpha.com/news/fda-hands-mindmeds-lsd-candidate-breakthrough-therapy-designation-in-generalised-anxiety-disorder-company-provides-12-week-data-and-fleshes-out-phase-3-program-plans https://psychedelicalpha.com/news/fda-hands-mindmeds-lsd-candidate-breakthrough-therapy-designation-in-generalised-anxiety-disorder-company-provides-12-week-data-and-fleshes-out-phase-3-program-plans"
X Link 2024-03-07T16:44Z 19.9K followers, [----] engagements
"P+ Psychedelic Bulletin #159 Patient Access re: MDMA-Assisted Therapy Doblin on the Future of Psychedelics Whole Mushroom vs. Synthetic Psilocybin Usona Launches Phase [--] Study BTDs Attract Investors for MindMed and Cybin And more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-159-patient-access-to-mdma-assisted-therapy-notes-from-sxsw-whole-mushroom-vs-synthetic-psilocybin https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-159-patient-access-to-mdma-assisted-therapy-notes-from-sxsw-whole-mushroom-vs-synthetic-psilocybin"
X Link 2024-03-21T17:39Z 19.9K followers, [----] engagements
"MindMeds Total Elimination of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies We look at MindMed's claim to have eliminated psychotherapy from its Phase 2b study and explore the broader Spravato-isation of PATs. https://psychedelicalpha.com/news/mindmeds-total-elimination-of-psychotherapy-in-lsd-study-stokes-debate-around-its-role-in-psychedelic-therapies https://psychedelicalpha.com/news/mindmeds-total-elimination-of-psychotherapy-in-lsd-study-stokes-debate-around-its-role-in-psychedelic-therapies"
X Link 2024-04-05T18:16Z 19.9K followers, [----] engagements
"Reunion Neuroscience Gets a New Lease of Life with $103M Series A to Fund Phase [--] Studies of 4-HO-DiPT Prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug"
X Link 2024-05-03T14:21Z 19.7K followers, [---] engagements
"Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals AbbVie has become the latest large pharmaceutical company to dip its toes into psychedelic drug development as it announced what might be the most substantial foray of its kind this morning. https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals"
X Link 2024-05-13T13:51Z 19.8K followers, [----] engagements
"Temporary Memorial at the Capitol Calls on FDA to Follow the Science and Approve Lykos MDMA A memorial in DC consists of [------] dog tags and bears the message APPROVE MDMA-ASSISTED THERAPY FOR PTSD. Photo: Grunt Style Foundation via LinkedIn"
X Link 2024-07-10T20:20Z 19.9K followers, 17.1K engagements
"Google co-founder backs Ibogaine biotech studying psychedelic African shrub Sergey Brins non-profit funds research into using hallucinogen for mental health treatment https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68 https://www.ft.com/content/5ed7daee-3d03-45d1-876b-52d81f0e2b68"
X Link 2024-07-21T14:28Z 19.9K followers, [----] engagements
"J&J Files Supplemental NDA with FDA Seeking Approval of Spravato as Monotherapy for Treatment-Resistant Depression If approved the esketamine nasal spray would become the first monotherapy for adults with TRD. https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-u-s-fda-approval-of-spravato-esketamine-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-u-s-fda-approval-of-spravato-esketamine-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression"
X Link 2024-07-23T11:10Z 19.9K followers, [---] engagements
"MindMed Announces $75M Public Offering Expected to close Monday. Cash will be used "to fund the research and development of its product candidates and working capital and general corporate purposes." https://www.businesswire.com/news/home/20240809560954/en/ https://www.businesswire.com/news/home/20240809560954/en/"
X Link 2024-08-09T15:16Z 19.9K followers, [----] engagements
"P+ Psychedelic Bulletin #170 - MindMed Tops Up Healthy Cash Balance with $75M Raise; Eyes Adding Depression to Pipeline - atai Approaches Ph [--] for DMT and R-MDMA Candidates - Compass Ph [--] Generally On-Track Potential for Slight Delay - & more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-170-is-mindmed-eyeing-depression-atai-approaches-phase-2-for-dmt-and-r-mdma-candidates-compass-phase-3-readout-timeline-european-psychiatrists-remain-open-to-psych"
X Link 2024-08-15T12:14Z 19.9K followers, [----] engagements
"What Does FDA Expect from Lykos Next Phase [--] MDMA Study (Part 2) Here we look at: - Accounting for Euphoria and Other Positive Adverse Events - Phasing Out Private Practices - Addressing Selection Bias - Give the Reins to a CRO https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-2 https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-2"
X Link 2024-08-28T13:52Z 20K followers, [---] engagements
"New Job Opportunity: Generalist (BD/Ops) at a Psychedelics Biotech Company More info. https://jobs.psychedelicalpha.com/generalist-business-development-operations-358b35816f95 https://jobs.psychedelicalpha.com/generalist-business-development-operations-358b35816f95"
X Link 2024-09-04T19:38Z 20K followers, [---] engagements
"Psychedelics for mental health among the 'biggest wellness trends of 2024' according to The Guardian. https://www.theguardian.com/wellness/article/2024/sep/04/2024-wellness-trends https://www.theguardian.com/wellness/article/2024/sep/04/2024-wellness-trends"
X Link 2024-09-04T19:48Z 20K followers, [---] engagements
"Cochrane Review finds that certainty of evidence is "low to very low" for psychedelic-assisted therapy in the treatment of anxiety depression and existential distress in people with life-threatening diseases. More: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015383.pub2/full https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015383.pub2/full"
X Link 2024-09-12T10:42Z 20K followers, 10.5K engagements
"Breaking: Psyence Biomed Backs Out of Clairvoyant Therapeutics Acquisition Less than a month after announcing it would acquire psilocybin drug developer Clairvoyant Psyence ($PBM) says it has walked away. https://www.globenewswire.com/news-release/2024/10/04/2958503/0/en/Psyence-Biomed-Provides-Update-on-Previously-Announced-Acquisition-of-Clairvoyant.html https://www.globenewswire.com/news-release/2024/10/04/2958503/0/en/Psyence-Biomed-Provides-Update-on-Previously-Announced-Acquisition-of-Clairvoyant.html"
X Link 2024-10-04T20:29Z 20K followers, [----] engagements
"Natural Medicine Advisory Bulletin [--] Vicente LLP looks at big-picture questions as the program hurtles towards launch. First up are fees and rule changes before the firm reviews Natural Medicine-related meetings since our last Bulletin in late Aug. https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-14 https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-14"
X Link 2024-10-24T16:09Z 20.5K followers, [---] engagements
"Sen. Kyrsten Sinema on MDMA-AT: It makes sense for Congress to keep it in the VA and DOD world and partner with the private community that is making leaps and bounds https://www.fiercehealthcare.com/health-tech/hlth-2024-recap-5-notable-trends-spotted-reporters-and-takeaways-executives#::text=Psychedelic%20medicine%20session%20draws%20a%20crowd https://www.fiercehealthcare.com/health-tech/hlth-2024-recap-5-notable-trends-spotted-reporters-and-takeaways-executives#::text=Psychedelic%20medicine%20session%20draws%20a%20crowd"
X Link 2024-10-28T16:36Z 20.5K followers, [----] engagements
""The FDA has never approved a drug before that requires certain type or length of therapy which MDMA would so this is uncharted territory". Sinema was speaking at HLTH 2024"
X Link 2024-10-28T16:36Z 20.5K followers, [---] engagements
"New Association Launches to Expand Patient Access to Psychedelic Medicines Founding members include Compass B. More Lykos Therapeutics and MindMed. The group's Scientific Advisors include Peter Hendricks Paul Huston Sandeep Nayak and Jennifer Jones. https://www.psychedelicsrx.org/new-association-launches-to-expand-patient-access-to-psychedelic-medicines/ https://www.psychedelicsrx.org/new-association-launches-to-expand-patient-access-to-psychedelic-medicines/"
X Link 2024-11-20T11:02Z 19.9K followers, [---] engagements
"P+ Psychedelic Bulletin [---] - Last-Minute Rule Changes Opt-Outs Ahead of Colorados Psychedelics Program Launch - Cybins $CYBN Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-181 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-181"
X Link 2024-11-22T16:54Z 20K followers, [----] engagements
"MindMed $MNMD CEO Robert Barrow tells Endpoints that the incoming Trump administration could potentially help slash some of the bureaucracy that hampers the development of psychedelic drugs. What were seeing is a broad willingness to engage and support efficiency he said"
X Link 2024-11-22T18:40Z 19.9K followers, [----] engagements
"What are Psychedelics Investors Excited About We take a close look at what psychedelics investors are most excited about using quantitative and qualitative data from our Q3'24 psychedelic investor survey. https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-excited-about https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-excited-about"
X Link 2024-11-25T14:00Z 20K followers, [---] engagements
"P+ Psychedelic Bulletin #182: - Psychedelics Insiders Trump [---] Wishlist - Doblin Reflects on Lykos Strategy - Polish Psilocybin Study Scores $4M in Funding - Alleged Killer of UnitedHealth CEO Apparently Interested in Psychedelics More. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-182-psychedelics-insiders-trump-2-0-wishlist-doblin-reflects-on-lykos-strategy-polish-psilocybin-study-scores-4m-in-funding"
X Link 2024-12-10T14:55Z 20K followers, [---] engagements
"- Reflecting on UW Madisons 4th Annual Psychedelic Symposium - MindMed Doses First Patient in Phase [--] LSD Program - Beckley Psytech Shares Small Cut of Data from Phase 2a Study of IV Psilocin in MDD - Psilocybin for COVID Clinicians - & more https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-183 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-183"
X Link 2024-12-18T18:00Z 19.9K followers, [---] engagements
"SCOOP: PSFCs $130M Roadmap to Shape the Future of Psychedelic Philanthropy https://psychedelicalpha.com/news/scoop-psfcs-130m-roadmap-to-shape-the-future-of-psychedelic-philanthropy https://psychedelicalpha.com/news/scoop-psfcs-130m-roadmap-to-shape-the-future-of-psychedelic-philanthropy"
X Link 2024-12-20T14:18Z 20K followers, [----] engagements
"Colorado's Department of Regulatory Agencies makes eleventh-hour changes to regulated psychedelics program rules to restrict at-home administration. Viability of microdosing via the program remains up in the air. https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-15-a-duplicitous-december https://psychedelicalpha.com/news/natural-medicine-advisory-bulletin-15-a-duplicitous-december"
X Link 2025-01-06T01:20Z 20K followers, [----] engagements
"Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblins Backing Now the companys board must decide whether to stick with its current lead investor Helena or accept Gracias proposal. https://psychedelicalpha.com/news/billionaire-investor-antonio-gracias-plots-100m-lykos-takeover-with-doblins-backing https://psychedelicalpha.com/news/billionaire-investor-antonio-gracias-plots-100m-lykos-takeover-with-doblins-backing"
X Link 2025-01-10T14:08Z 19.9K followers, [----] engagements
"The PsychedeliCare Initiative launches effort to gather 1M+ signatures in support of the European Commission taking meaningful action re: funding psychedelic research standardising psychedelic therapy approaches and rescheduling psychedelics. https://psychedelicalpha.com/news/psychedelicare-launches-first-european-citizens-initiative-demanding-political-action-on-psychedelic-assisted-therapies https://psychedelicalpha.com/news/psychedelicare-launches-first-european-citizens-initiative-demanding-political-action-on-psychedelic-assisted-therapies"
X Link 2025-01-14T10:57Z 19.9K followers, [---] engagements
"2025 Florida Farm Bill Closes 'Loophole' for Sale of Psychedelic Mushrooms Press release says the bill includes: "Eliminating the loophole for the sale of psychedelic mushrooms.""
X Link 2025-02-04T19:25Z 19.9K followers, [----] engagements
"The psychedelics field has lost a champion at the VA as Shereef Elnahal vacates his post as Under Secretary for Veterans Health. He has since revealed that he has taken a position as Executive Health Advisor to VC firm Thrive Capital. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-188-q424-lobbying-update-virginia-lawmakers-question-purpose-precedent-of-compass-bill-va-loses-psychedelics-champion-gh-discusses-lack-of-placebo-effect"
X Link 2025-02-14T21:27Z 20.1K followers, [---] engagements
"LSD Microdosing Not Effective for ADHD The results from the first randomised trial of microdosing LSD for ADHD are in: "LSD was not efficacious in reducing ADHD symptoms compared with placebo""
X Link 2025-03-20T03:38Z 19.9K followers, [----] engagements
"Christian Angermayers psychedelic drug developer $ATAI has announced that it is adding $5M worth of Bitcoin to its treasury. In an article published on LinkedIn Angermayer wrote about What Psychedelics and Bitcoin have in common. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-192-psychedelic-safety-compass-lacklustre-long-term-data-lsd-microdosing-no-better-than-placebo-in-adhd https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-192-psychedelic-safety-compass-lacklustre-long-term-data-lsd-microdosing-no-better-than-placebo-in-adhd"
X Link 2025-03-28T14:42Z 20.1K followers, [---] engagements
"Psychedelic Alpha Launches TripRadar We are very pleased to launch our latest product: TripRadar which allows you to see share and sync with the global psychedelic experience in real time. Our new app has several unique features"
X Link 2025-04-01T15:00Z 20.5K followers, [----] engagements
"Will MDMA be FDA-approved by the end of [----] Yes No Yes No"
X Link 2025-04-08T21:58Z 20.1K followers, [---] engagements
"In late June $CMPS will readout the first of two Ph [--] studies of psilocybin for treatment-resistant depression. It's seen by many as make-or-break for the company and will have ramifications for the broader field of psychedelic drug devs. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-194-make-or-break-moment-looms-for-compass-rfk-jr-discusses-lsd-use-europes-next-chapter-in-psychedelic-therapy-begins-in-barcelona"
X Link 2025-04-27T16:24Z 20.2K followers, [---] engagements
"Otsuka Eyes Psychedelic Future in Japan with New Infrastructure Drive Otsuka has announced a joint research agreement to build infrastructure for the social implementation of psychedelics in Japan long defined by strict drug laws & deep stigma. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans"
X Link 2025-05-09T15:12Z 20K followers, [----] engagements
"Psychedelic Alpha Readers Cautiously Optimistic Re: Compass Pathways' ( $CMPS ) Upcoming Phase [--] Readout Last week we asked what sort of results you're expecting from Compass Phase [--] psilocybin for treatment-resistant depression study readout expected in late June"
X Link 2025-05-11T14:26Z 20.2K followers, [----] engagements
"Half of ASCP 2025's Pharmaceutical Pipeline Features Psychedelics In our latest Bulletin we review the dozens of poster and presentation abstracts to bring you a preview. More: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-196-otsuka-eyes-psychedelic-future-in-japan-first-look-at-gilgameshs-phase-2a-data-ascp-2025-preview-va-sec-pressed-on-psychedelics-plans"
X Link 2025-05-12T15:14Z 20K followers, [----] engagements
"Psychedelics in Japan: A Conversation with Dr. Hiroyuki Uchida Our first bilingual interview features a conversation with the man at the forefront of psychedelic research in Japan: @Uchida_Keio_Psy. https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead"
X Link 2025-05-21T14:18Z 20K followers, [----] engagements
"Carolina Seybert psychologist and researcher at Champalimaud Foundation reflects on an event last Monday that saw the leaders of a half-dozen Portuguese health-related professional bodies launch their recommendations on the clinical use of psychedelics. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-197-portugese-health-related-professions-unite-on-psychedelics-shrooms-shots-and-the-next-surgeon-general-religious-leaders-study-set-to-publish"
X Link 2025-05-21T15:09Z 20K followers, [---] engagements
"In a recent interview with Psychedelic Alpha researcher @Uchida_Keio_Psy explained how various elements of psychedelic research and roll-out must be attuned to the Japanese context. Read more in the full interview available in both English & Japanese: https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead https://psychedelicalpha.com/news/psychedelics-in-japan-dr-hiroyuki-uchida-on-studies-stigma-and-the-road-ahead"
X Link 2025-05-21T19:24Z 20K followers, [---] engagements
"BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria. https://psychedelicalpha.com/news/breaking-atai-moves-to-acquire-beckley-if-phase-2b-5-meo-dmt-data-delivers https://psychedelicalpha.com/news/breaking-atai-moves-to-acquire-beckley-if-phase-2b-5-meo-dmt-data-delivers"
X Link 2025-06-02T10:10Z 20.2K followers, 14.1K engagements
"After a sluggish start $ATAI stock is up 11.5% today. On the monthly it's up 72%. BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria. https://t.co/6jOb1U9SEy BREAKING: atai Moves to Acquire Beckley If Phase 2b 5-MeO-DMT Data Delivers $ATAI has struck an option-like deal with Beckley Psytech: it will acquire the latter in an all-share transaction should its Phase 2b readout meet prespecified criteria."
X Link 2025-06-02T16:59Z 20.3K followers, [----] engagements
"Speaking at Prague Castle @RickDoblin of @MAPS presents on the potential of psychedelic therapies for war veterans. As part of his presentation he shared our Psychedelic Drug Development Bullseye Chart among other resources"
X Link 2025-06-09T11:18Z 20.1K followers, [---] engagements
"Can Czechia Deliver on Psilocybin Access and Provide a Model for the Continent In Bulletin [---] we took a deep dive into that question. Read the full analysis for free: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-200-can-czechia-deliver-on-psilocybin-access-a-closer-look-at-atai-beckley-q125-psychedelic-lobbying-update-catching-up-with-the-class-of-bulletin-100 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-200-can-czechia-deliver-on-psilocybin-access-a-closer-look-at-atai-beckley-q125-psychedelic-lobbying-update-catching-up-with-the-class-of-bulletin-100"
X Link 2025-06-10T18:26Z 20.1K followers, [---] engagements
"Texas Governor Greg Abbott has signed SB [----] the Texas Ibogaine Initiative into law. Read more in Bulletin 201: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-201-dispatches-from-prague-and-london-texas-becomes-leader-in-ibogaine-research-as-governor-signs-50m-match-funding-bill-high-dose-lsd-shows-potential-in-depression-but-fi https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-201-dispatches-from-prague-and-london-texas-becomes-leader-in-ibogaine-research-as-governor-signs-50m-match-funding-bill-high-dose-lsd-shows-potential-in-depression-but-fi"
X Link 2025-06-13T15:28Z 20.1K followers, [----] engagements
"Australias largest health insurance company Medibank has carved out AUD $10M (USD $6.5M) to fund a psychedelic therapy pilot program for its eligible members who wont pay a penny in out-of-pocket costs. More: https://psychedelicalpha.com/news/australias-largest-private-health-insurer-commits-10m-to-fund-mdma-therapy-for-ptsd-in-first-of-its-kind-program https://psychedelicalpha.com/news/australias-largest-private-health-insurer-commits-10m-to-fund-mdma-therapy-for-ptsd-in-first-of-its-kind-program"
X Link 2025-06-18T00:30Z 20.2K followers, [----] engagements
"Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://psychedelicalpha.com/news/compass-pathways-psilocybin-clears-first-phase-3-hurdle https://psychedelicalpha.com/news/compass-pathways-psilocybin-clears-first-phase-3-hurdle"
X Link 2025-06-23T10:33Z 20.5K followers, 31.5K engagements
"$CMPS opens 33% down with marketcap shaved to $300M at the time of writing. Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://t.co/wF6AOPneSu https://t.co/ee7f0zAngc Compass Pathways Psilocybin Clears First Phase [--] Hurdle Rest assured weve got something pretty special here $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. https://t.co/wF6AOPneSu https://t.co/ee7f0zAngc"
X Link 2025-06-23T13:31Z 20.5K followers, [----] engagements
"Cautious Optimism Lingering Questions: Researchers React to Compass Phase [--] Psilocybin Results We spoke with @Uchida_Keio_Psy @AicherHelena @TheBorisLab @trpwolff @thebandlab and others for our researchers react piece. https://psychedelicalpha.com/news/cautious-optimism-lingering-questions-researchers-react-to-compass-phase-3-psilocybin-results https://psychedelicalpha.com/news/cautious-optimism-lingering-questions-researchers-react-to-compass-phase-3-psilocybin-results"
X Link 2025-06-25T15:22Z 20.2K followers, [----] engagements
"P+ Psychedelic Bulletin #202: - Psychedelics Access Within [--] Months RFK Jr. Says; Psychedelics in Washington - Lykos New CEO CMO - New Zealands First Psilocybin Prescriber - Judge Recommends Schedule I Placement for DOI and DOC - and more. https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-202-psychedelics-access-within-12-months-rfk-jr-says-psychedelics-in-washington-lykos-new-ceo-cmo-new-zealands-first-psilocybi"
X Link 2025-06-27T19:15Z 20.3K followers, [---] engagements
"Last week New Zealands Deputy Prime Minister David Seymour announced that one highly experienced psychiatrist has been granted permission to prescribe psilocybin to patients with treatment-resistant depression. That psychiatrist is Dr Cameron Lacey who led the first trial of psilocybin in the country. The Deputy PM described the move as huge for people with depression whove tried everything else and are still suffering. Read more in Bulletin 202:"
X Link 2025-06-29T15:57Z 20.3K followers, [---] engagements
"In a decision issued on June 20th World Psychedelics Day a Drug Enforcement Administration (DEA) Administrative Law Judge recommended the placement of DOI and DOC in Schedule I. The lawyers behind the challenge to that action were Robert Rush and Brett Phelps. The pair say that they are prepared to fight these terrible attacks on psychedelic science. Read more in Bulletin 202: https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-202-psychedelics-access-within-12-months-rfk-jr-says-psychedelics-in-washington-lykos-new-ceo-cmo-new-zealands-first-psiloc"
X Link 2025-07-03T13:05Z 20.2K followers, [---] engagements
"Prof Andrew McIntosh is hoping to establish a ketamine clinic at the Royal Edinburgh Hospital for patients with treatment-resistant depression. A small number of private clinics offer ketamine for depression in the UK and the Oxford Health NHS Foundation Trust offers it too. But all of those options are self-pay which is something of a foreign concept to many Brits who rely on the National Health Service to provide healthcare that is free at the point of access. McIntosh is hoping to secure funding from the Scottish government. Read more in Bulletin 202:"
X Link 2025-07-04T14:06Z 20.3K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::Psyched_Alpha